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ABSTRACT 
Nervous system injury leads to the permanent loss of sensory and motor functions. Injectable 
hydrogel containing therapeutic agents can be directly injected to the injured cavity as a promising 
approach for minimally-invasive treatment of nerve injury. However, such injectable hydrogels 
have not been well developed and documented in the literature. As inspired, this project aims to 
develop injectable collagen-based gels for nerve injury repair and to characterize in vitro for 
supporting neurite outgrowth of dorsal root ganglia (DRG) explants and dissociated neurons. 
To develop collagen-based gels, collagen at varying concentrations (e.g. 1.5, 2 and 2.5 mg/mL) 
were used to form gels under physiological conditions and genipin (0.25-5 mM) were applied as 
the chemical crosslinker. Characterization studies showed that collagen-based hydrogels could 
form porous and fibrillary gels within a time period of 40 s at 37 °C and genipin could significantly 
improve the mechanical property of gels and the resistance to degradation.   
To evaluate the cytotoxicity of the injectable hydrogels and compare the cell behaviour in 
two-dimensional (2D) and three-dimensional (3D) environments, rat primary Schwann cells 
(PRSCs) were seeded onto and encapsulated within the gels, and the cell viability was examined 
at Day 3 by the Live/Dead assay. The results showed that collagen gels provide superior support 
for PRSCs survival in both 2D and 3D cultures, for example, with a cell viability of 96 % and 
95 %, respectively, for the collagen gel with a concentration of 1.5 mg/mL. Collagen chemically 
crosslinked by genipin at 0.25 and 0.5 mM exhibited a permissive but less favorable environment 
to PRSCs comparing with pure collagen. Genipin over 1 mM inhibited the PRSCs survival 
significantly in both 2D and 3D cultures.  
 DRG explant and dissociated neuron cultures were examined as in vitro cell models to 
evaluate the therapeutic efficacy of collagen and collagen-genipin gels for nerve injury repair and 
the cellular response was also characterized and compared to each other. Preliminary 2D cultures 
were shown to greatly support neurite extension and 2.5 mg/mL collagen gel supported the most 
neurite extension and branching development. It was shown that genipin had a significant effect 
on the neurite density but not neurite length of DRG explants, whereas the dissociated neurons 
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were more sensitive to genipin. Enrichment of culture medium with nerve growth factor (NGF) 
could significantly enhance the neurite length and density. 
PRSCs as the supportive cells were co-cultured with DRG explants/dissociated neurons in 
3D hydrogels. Confocal microscopy showed that the neurites of DRG explants and dissociated 
neurons could extend freely within the physical collagen gels, and dissociated neurons exhibited 
pseudo-unipolar phenotype in 3D environment indicating true axonal extension. Moreover, 
genipin had a significantly inhibitory effect on dissociated neurons whereas the explants were more 
tolerant to genipin possibly due to the preserved cellular components and interactions. It was also 
shown that hydrogels infiltrated with PRSCs could enhance the neurite elongation and branches 
dramatically. Our research has determined the therapeutic potency of injectable collagen-based 
gels containing the PRSCs for nerve injury repair and gained new insights into the use of the 
injectable gel as a delivery substrate in neural tissue engineering.  
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CHAPTER 1  
INTRODUCTION  
1.1 Nervous System Injury 
1.1.1 Physiology of the Nervous System  
The nervous system can be fundamentally divided into the central nervous system (CNS) and 
the peripheral nervous system (PNS). Neurons and neuroglial cells are the main cellular 
components of both the CNS and PNS. A neuron is composed of a cell body, axon and dendrites 
(Figure 1.1 (a)). The axon is a long process emitting from the cell body and transmits action 
potentials away from the soma, whereas dendrites are short processes carrying electrical messages 
towards the cell body. Besides the neurons, the glial cells play important roles in supporting the 
neurons’ growth, producing neurotrophic factors, myelinating the axon, etc. Glial cells in the CNS 
consist of microglia, astrocytes, oligodendrocytes and ependymal cells. Those in the PNS include 
Schwann cells, satellite cells and enteric glia cells. Axons can be myelinated by oligodendrocytes 
in the CNS, whereas the myelinating cells are Schwann cells in the PNS. Moreover, an individual 
axon is myelinated by a series of single Schwann cells in the PNS, whereas one oligodendrocyte 
can myelinate several CNS axons (Figure 1.1 (b)). 
The CNS is composed of the brain and spinal cord. In spinal cord, a butterfly-shaped gray 
matter and white matter (Figure 1.2) arrangement is observed. The neural cell bodies, dendrites 
and glial cells locate in gray matter, whereas the white matter contains mostly oligodendrocytes 
and bundles of myelinated axons, which appear white in color. The gray matter of the spinal cord 
has pairs of projections into the surrounding white matter, including ventral horn and dorsal horn. 
Sensory signals enter into the dorsal horns of the gray matter via the dorsal roots. The dorsal root 
contains bundles of sensory axons, whereas the somas of sensory neurons are located in the dorsal 
root ganglia (DRG). The spinal cord is defined as part of the CNS, but the DRG is considered parts 
of the PNS. The PNS includes all of the cranial and spinal nerves arising from the brainstem and 
spinal cord. Nerves consisting of numerous axons convey sense signals inward to the CNS and 
motor messages outward to the rest of the body [1]. 
   2 
Figure 1.1 (a) Structure of a typical neuron; (b) Myelin sheath of the CNS and PNS axon. 
Figure 1.2 Cross-section of spinal cord and the overview of the signal conduction. 
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1.1.2 CNS Injury and Regeneration 
Injury to the spinal cord and brain can lead to the catastrophic and permanent loss of sensory 
and motor functions. These injuries can result from a trauma (falls, gunshot wounds and vehicle 
accidents), stroke or genetic disorder. A key difference between the CNS and PNS is the inability 
of axonal regeneration in the CNS. Interestingly, the injured DRG can undergo axonal sprouting 
and regeneration in the PNS, but axonal regeneration stops entering the spinal cord at the dorsal 
root entry zone [2-4]. Besides the intrinsic inability of axonal regeneration in the CNS, the 
challenges of the CNS regeneration include the inhibitory glial environment, the glial scar 
surrounding the lesion site and the lack of neurotrophic factors [5] (Figure 1.3).  
After a CNS injury, the myelin sheaths become damaged and the axons are exposed to the 
inhibitory environment. Many inhibitory molecules responsible for the failure of CNS regeneration 
have been identified, such as Nogo, myelin-associated glycoprotein (MAG), oligodendrocyte 
myelin glycoprotein (OMgp), etc. [6-13]. Researchers have found that neutralization of the 
inhibitory environment can promote axonal sprouting. For example, blockade of Nogo-A, MAG 
and OMgp have shown to promote the growth cone formation and axonal regeneration [14-20].  
In addition to the damaged myelin, the glia scar is another barrier to the axonal regeneration. 
After the CNS injury, the astrocytes can isolate the lesion site and alleviate the inflammation to 
avoid further damage. However, the reactive astrocytes around the injured area can proliferate and 
form the glial scar [21, 22]. Studies have shown that the glial scar not only is a physical barrier but 
also releases chemical inhibitors, such as chondroitin sulphate proteoglycans (CSPGs) [23-26]. 
Researches have shown that axons stop growing once reaching the glial scar site [27, 28]. 
Modification of the CSPGs allows axons to regenerate around the lesion site [29-32].  
Advances in recent years have identified many inhibitory molecules and characterized the 
potential inhibitory mechanisms after the CNS injury. However, clinical treatment is still very 
limited. In addition to the administration of the anti-inflammatory drug (methylprednisolone)  
and physical rehabilitation, other clinical therapies are still in experimental stages [33, 34]. Current 
clinical treatments target on the inflammation control and maintenance of the existing muscle 
function, whereas completely functional recovery after the CNS injury is rarely achieved. 
Therefore, to improve long-distance axonal regeneration and hence functional recovery, further 
attempts should focus on not only addressing the inhibitory environment but also stimulating the 
intrinsic growth of the neurons to achieve functional regeneration.  
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Figure 1.3 Illustration of the CNS injury (spinal cord). After the CNS injury, many myelin sheaths 
are damaged and the reactive astrocytes start to proliferate to form the glial scar, which is inhibitory 
to the nerve regeneration. Cysts filled with fluid usually exist at the injured site. 
1.1.3 PNS Injury and Regeneration 
PNS injury can result from traumatic or non-traumatic incidents which may lead to great loss 
of sensory and motor functions. After a peripheral nerve is transected, a series of response from 
the proximal and distal ends are induced (Figure 1.4 (a-b)). Within hours of injury, the proximal 
ends of the severed axons are sealed and swollen due to the enrichment of organelles. The distal 
stump undergoes a calcium-mediated process called the Wallerian degeneration. During Wallerian 
degeneration, the damaged axons disconnect from the cell body, and severed axons and myelin 
break down into fragments. Schwann cells and macrophages then play a key role in removing 
axonal and myelin debris from the distal injury site. This cleaning process may require one week 
to several months [35-37]. 
Unlike the CNS injury, nerves can regenerate by themselves in the PNS if the injury gap is 
small. Following the debris clearance, axons begin to sprout and regenerate at the nodes of Ranvier 
of the proximal end and re-innervate towards the distal end (Figure 1.4 (c)). During axonal 
regeneration, Schwann cells also promote the formation of a basal lamina and release growth 
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factors and cytokines to guide the axonal outgrowth [38, 39]. Functional recovery may be partially 
achieved after several months to years, depending on the levels of injury. However, if the nerve 
gap is big, autologous nerve grafts are required to connect the two ends of the damaged nerves. 
Even though autografts provide superior biocompatibility, there are disadvantages including the 
trauma to the donor site. Complete functional recovery is rare, especially when the defects are 
extensive [40]. Further research should be focused on the development of alternative repair-
promoting devices to the grafts, and combinations of cellular and molecular therapies to aid the 
nerve regeneration.  
Figure 1.4 Illustration of the PNS injury and regeneration. After the peripheral nerve is injured (a), 
the proximal end becomes swollen and the distal axons are disconnected from the cell body. (b). 
Following debris clearance by the macrophages, Schwann cells can promote axonal regeneration 
(c). 
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1.1.4 DRG as In Vitro Models for Nerve Injury Repair 
DRG are swellings beside the spinal cord in which the cell bodies of primary sensory neurons 
reside (Figure 1.2). Sensory neurons of adult rats exist in vivo as mostly pseudo-unipolar 
morphology and convey sensory signals from the periphery to the CNS. The pseudo-
unipolarization (transforming from bipolar form) occurs during prenatal development (Figure 1.5) 
[41, 42]. Each sensory neuron has one single axon with afferent branches projecting to the spinal 
cord and the PNS [39]. Even though DRG neurons have axons in both the CNS and PNS, only 
their peripheral end can regenerate in vivo due to the different glial environment in the CNS and 
PNS [2-4]. The reaction of DRG after the PNS and CNS injury has been widely investigated. It 
has been demonstrated that injury to the PNS and CNS can result in neuronal cell death in DRG 
[43-45]. The fundamental challenge for the CNS or PNS injury repair is the lack of successfully 
axonal elongation. Since DRG is closely related to the CNS and PNS injury, it can be exploited as 
the excellent in vitro cell models to evaluate the therapeutic potency of biomaterials, molecular 
and cellular therapies for nerve injury repair. And the neurite/axonal outgrowth of DRG sensory 
neurons can be used to evaluate nerve regeneration potential and provide important insights into 
new therapies in vitro. 
Recent advances have shown that the central axons of DRG can access beyond the dorsal root 
entry zone and enter into the spinal cord with the support of neurotrophic factors such as 
neurotrophin-3 (NT-3), nerve growth factor (NGF) and glial cell line-derived neurotrophic factor 
(GDNF) after dorsal root injury [46, 47]. Research of suitable substrates delivering those 
neurotrophins and supportive cells to the injured site has drawn great attention for long-distance 
nerve injury repair. In our research, DRG explants and dissociated neurons are employed as in 
vitro models to study the effect of injectable hydrogels carrying Schwann cells on axonal 
outgrowth.  
Adult rat DRG can be directly dissected as explants or dissociated into the individual sensory 
neurons as shown in Figure 1.6 [48]. Each model has its own advantages and disadvantages. DRG 
explants are clusters of sensory neurons and glial cells. The unique advantages of the DRG explant 
model are simulation of the original state in vivo, and preservation of the original cell components 
in DRG and their cell-cell interactions, which are lost in the DRG dissociated neuron model. 
Comparing with the DRG explant model, dissociated DRG neuron offers a great opportunity to 
unveil how therapies affect the axonal regeneration of individual sensory neuron while minimizing 
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other influences [49]. Mature DRG sensory neurons exist as mostly pseudo-unipolar form in vivo, 
whereas in vitro culture of sensory neurons shows bipolar and multipolar morphology [50]. It has 
been demonstrated that the DRG explant and dissociated neuron cultures respond to many 
guidance neurotrophins including NT-3, NGF, GDNF and brain-derived neurotrophic factor 
(BDNF) [51-53]. Co-cultures with Schwann cells also enhance axonal regeneration, which is 
coordinated with the cell transplantation results in animal models [54]. The DRG culture offers 
great opportunities to model axonal regeneration in vitro. And the easy control and manipulation 
of the extrinsic factors in the DRG culture environment make it a powerful tool to study nerve 
injury repair in vitro.  
 
Figure 1.5 Basic neuron types: unipolar, bipolar and multipolar morphology. 
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Figure 1.6 Schematic views of the DRG explants and dissociated sensory neurons. 
1.2 Tissue Engineering Strategies for Nerve Injury Repair 
To date, many promising advances in tissue engineering have been achieved in promoting 
and guiding the axonal regeneration for nerve injury repair, such as the conduit or scaffold system, 
delivery of supportive cells and bioactive molecules, or combinational therapies. Major tasks of 
neural tissue engineering aim at developing or manufacturing devices to improve the connectivity 
of the injured site, neutralize the inhibitory environment after injury, enhance the intrinsic ability 
of axonal regeneration, and promote physical guidance and re-myelination of regenerating axons 
[55]. Progresses in neural tissue engineering are briefly reviewed in the following aspects: 
guidance, cellular and molecular therapies.   
1.2.1 Guidance Therapy 
For PNS injury, an autologous nerve graft is the standard clinical treatment when the nerve 
gap is big. However, this treatment induces problems of sensation loss and morbidity at the donor 
site, potential neuropathic pain and relatively low success rate of fully functional recovery [35]. In 
the past few years, enormous efforts have been made in studying alternatives to autologous nerve 
grafts and manufacturing the nerve guidance devices and fillings for nerve injury repair. 
The guidance device can either be a conduit [56] or a patterned scaffold which simulates the 
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nerve autograft to connect the lesion gap and guide axonal regeneration. Researchers have 
successfully fabricated the nerve guidance conduits with naturally derived materials including 
hyaluronic acid [57], collagen [58], alginate[59], fibrin [60] or synthetic polymers [61]. Novel 
manufacturing techniques, including rapid prototyping, also lead to more controllable architecture 
and microstructure of patterned scaffolds. Several biodegradable nerve conduits have been 
approved by the US Food and Drug Administration (FDA) for the peripheral nerve repair. Most of 
the approved conduits (NeuraGen®, Neuroflex®, NeuroMend®, and NeuroMatrix®) are comprised 
of type-I collagen. It has been reported that the collagen-based conduits demonstrated supportive, 
semipermeable and protective environment for nerve regeneration in vitro and in vivo [62-64]. 
However, the defect length applied for the collagen conduits is limited up to 3 cm [65, 66] and the 
functional recovery is not equivalent to nerve autografts [67]. To achieve equivalent or excessive 
therapeutic effect as the nerve autografts, combinational strategy should be considered. 
Researchers have directly infiltrated Schwann cells, stem cells, or nerve growth factors into the 
hollow conduits to assist nerve repair and studies have shown significant enhancement of axonal 
regeneration along the conduits walls at 2 weeks [68, 69]. To deliver the therapeutic agents in an 
efficient and prolonged manner, injectable hydrogels can be adopted to encapsulate the cells and 
neurotrophic factors as the therapeutic additives.  
Comparing with the PNS injury, complex regenerative obstacles exist around the CNS injury 
site and impede the functional recovery significantly. Unfortunately, successfully functional 
recovery of CNS has not been achieved through current treatments. To date, advances in tissue 
engineering provide remarkably promising strategies for the CNS injury repair. A wide variety of 
tissue-engineered devices applied for the CNS injury have been investigated. These devices 
include the hydrogels, nanofibrous scaffolds, single and multi-channel guidance conduits [55, 70]. 
Injectable hydrogels have unique advantages over other types of devices. Direct injection of 
hydrogel solution enriched with ant-inflammatory drugs, supportive cells and neurotrophic factors 
into the lesion site could fill the void and localize in situ to establish a permissive environment for 
nerve injury repair. Most importantly, injectable hydrogels provide minimally invasive procedures 
when compared to other surgical implants especially for the most common focal types of injury. 
1.2.2 Cellular Therapy  
Various types of cells have been extensively investigated to stimulate axonal sprouting and 
improve nerve regeneration. Those cells include glial cells (Schwann cells, astrocytes), stem or 
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progenitor cells, and olfactory ensheathing cells [34, 40, 63, 71]. Comparing with other cells, 
Schwann cells have unique advantages of secretion of multiple growth factors and potentially 
autologous sources. In our project, rat primary Schwann cells (PRSCs) were seeded onto or 
encapsulated within the injectable hydrogels to evaluate the potency of cell-delivery substrates on 
neurite outgrowth of DRG in vitro. Here, we review some progresses with the emphasis on PRSCs 
for nerve injury repair.  
PRSCs are glial cells found in the PNS and hold significant promise for both the CNS and 
PNS repair. In life, they not only insulate and protect the PNS axons with myelin sheaths, but also 
lead to a more permissive environment by expressing and secreting nerve growth factors (NT-3, 
BDNF and GDNF) [72, 73] and extracellular matrix (ECM) components (collagen, laminin and 
fibronectin) [74, 75], which are essential for the neuronal survival and axonal extension. 
Transplantation of PRSCs to the lesion site in vivo has been shown to aid the nerve regeneration 
applied for both the PNS and CNS injury [76-79]. However, the application of autologous PRSCs 
is limited due to the time-consuming isolation and expansion process. 
Following the PNS injury, PRSCs play important roles in bridging the lesion gap, re-
myelinating regenerated axons, and providing guidance and neurotrophic support [38]. When a 
large injury gap exists, combinational strategy of PRSCs and tissue-engineered devices has been 
adopted to achieve enhanced nerve recovery. Compared to the conduit only, hollow collagen 
conduit infiltrated with PRSCs has shown to support more regenerated axons and enhanced 
functional recovery in vivo compared to conduit only [80]. Collagen sheets with PRSCs attached 
were rolled to efficiently increase the number of adherent cells and implanted to the rat sciatic 
nerve. Conduit containing the PRSCs has shown to improve the functional recovery than conduit 
only and the efficacy is dependent on the numbers of PRSCs [81]. Hydrogel containing the PRSCs 
can be applied as the conduit filling and has demonstrated enhanced nerve recovery [82-87]. In 
general, PRSCs-loaded conduits are beneficial for large gap injury with the length up to 6 cm [88], 
and enhanced nerve regeneration has been demonstrated compared to conduit only, but still not as 
good as the autografts. 
As described earlier, injured CNS axons cannot regenerate by their own due to multiple 
factors. Although PRSCs are absent in the native CNS environment, extensive experiments have 
shown that transplantation of PRSCs can enhance axonal regeneration by clearing the debris [89], 
reducing cystic cavity [90, 91], re-myelinating axons and producing neurotrophins [77, 92]. Direct 
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injection of PRSCs to the injured site has shown positive effects on promoting the outgrowth of 
DRG axons and reducing the posttraumatic cavitation after spinal cord injury [71, 76]. Polymer 
conduit filled with PRSCs and MatrigelTM mixture has demonstrated improved axonal outgrowth 
and elongation compared to conduit and conduit-MatrigelTM only [78]. However, the regenerated 
axons fail to leave the transplantation site and the migration of PRSCs in white matter is restricted 
probably due to the intrinsically inhibitory environment [40]. Therefore, additional strategies are 
required to enhance the efficacy of nerve regeneration for the CNS injury including incorporation 
of neurotrophic factors and the aid of tissue-engineered devices.  
1.2.3 Molecular Therapy 
The neurotrophin family includes NGF, BDNF, NT-3 and neurotrophin-4/5 (NT-4/5). 
Additional proteins with neurotrophic properties include GDNF and CNTF. Extensive research 
has demonstrated that the neurotrophic factors can promote neuronal survival, axonal outgrowth 
and branching development [93-95]. Among the neurotrophin family, NGF has been one of the 
most extensively investigated neurotrophic factors. In our project, NGF was supplemented into the 
culture medium to evaluate the efficacy of neurotrophins on neurite outgrowth of DRG neurons. 
The following section will review the studies of NGF in neural tissue engineering. 
NGF is crucial during the development of the nervous system and plays important roles in 
nerve regeneration after the PNS or CNS injury. Firstly, studies have shown that NGF could 
promote the survival and outgrowth of sensory neurons [96]. The mini-pump delivery of NGF, 
NT-3 and GDNF (but not BDNF) leads to the outgrowth of damaged axons and functional 
regeneration after dorsal root injury [46]. NGF can also be delivered by gene-modified fibroblast 
grafts, which has been demonstrated to induce robust neurite outgrowth of sensory neurons into 
the injured spinal cord [97]. However, extensive sprouting of the non-injured sensory axons caused 
by NGF is probably associated with chronic pain [98, 99].  
To deliver the neurotrophin to the injured site in an efficient and controllable manner, tissue-
engineered devices are widely used to encapsulate and release neurotrophic molecules. NGF could 
be integrated into a wide range of devices, such as conduits, microspheres, hydrogels, scaffolds, etc., 
and delivered via diffusion or released with the degradation of the devices [55]. Alginate, chitosan, 
poly (lactic acid) (PLA), poly (glycolic acid) (PGA), etc. have been frequently used to fabricate 
microspheres which hold great promise for the controlled release of biomolecules. The nerve conduits 
loaded with NGF-filled microspheres lead to dense fiber outgrowth of rat sciatic nerve gap compared 
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to the negative control groups [100]. Hydrogel is another superior substrate for the prolonged delivery 
of the neurotrophic factors. It has been demonstrated that hydrogels of low stiffness such as collagen, 
laminin or fibrin induce enhanced nerve regeneration than stiffer gels [101]. Moreover, NGF with 
gradient concentrations within the hydrogels has shown to guide the axonal outgrowth to the 
correct targets [102, 103].  
1.3 Injectable Hydrogel for Nerve Injury Repair 
Compared with the preformed scaffolds, injectable anisotropic hydrogels for nerve injury 
repair have recently drawn much attention due to the minimally invasive injection procedure, 
simulation of in vivo environment, improved graft integration, the capacity of filling the cavity of 
the injured site, etc [104, 105]. Prior to the injection, bioactive molecules and supportive cells can 
be incorporated by mixing with the hydrogel solution. Once injected to the lesion site, the 
injectable system will conform to the cavity shape and gel in situ under physiological conditions 
(Figure 1.7). Following gelation, these matrices could not only provide guidance and support for 
the regenerated axons but also prolong the delivery of therapeutic agents for nerve injury repair. 
Injectable hydrogel could be directly injected into the cyst after the CNS injury or accommodated 
within the nerve conduit for the PNS injury considering the requirements of mechanical support 
(Figure 1.8). 
1.3.1 Materials 
A wide variety of naturally-derived materials and synthetic polymers have been extensively 
investigated for nerve injury repair. To optimize and select the best candidate, a few design 
parameters need to be considered, including: biocompatibility, swelling behaviour, degradation 
rate, gelation property (gelation temperature, gelation time and gel strength), porosity, support for 
neural survival and neurite outgrowth, etc.  
Natural materials featuring the superior biocompatibility can be divided into protein-based 
(collagen, fibrin, hyaluronic acid and MatrigelTM) and polysaccharide-based (agarose, chitosan, 
methyl cellulose and alginate). To varying degrees, they can simulate the native ECM environment 
and provide a permissive environment for nerve regeneration. However, rapid degradation in vivo 
may limit their applications in many cases. In contrast, synthetic materials, such as poly(ethylene 
glycol) (PEG), poly(vinyl alcohol) (PVA), poly(glycolic acid) (PGA) and poly(lactic acid) (PLA), 
can provide a finely tunable degradation rate, greater mechanical strength, tailorable functional 
groups, etc. However, incompatibility with cell adhesion and neurite outgrowth has motivated the 
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modification of these synthetic polymers. By the covalent crosslinking of the reactive functional 
groups and biomolecules or combining with other natural materials, they may show great potential 
in neural tissue engineering [104, 106]. Here, we review some widely investigated natural 
materials. 
Type I collagen is the major component of ECM throughout the body and has been 
extensively investigated for nerve injury repair. Also, several collagen-based products including 
nerve conduits, matrices, etc. have achieved approvals from the FDA [107, 108]. Gelation of 
collagen can be induced at physiological conditions. Research has demonstrated the favorable 
environment of collagen gels for neural survival and neurite outgrowth for both the injured CNS 
and PNS [109-111]. Due to the non-load bearing nature of spinal cord and brain, the collagen 
solution can be directly injected to the lesion site and fill the cavity in situ. Collagen gels can also 
be used as the fillings of the nerve conduits which hold great promise and exhibit positive outcomes 
for PNS injury [112]. Moreover, the amino acid sequences on collagen contain biologically 
adhesive sites for the supportive cells.  
Given the rapid degradation of collagen gels in vivo, chemical crosslinkers (glutaraldehyde, 
diphenylphosphoryl azide, genipin, etc.) may be required to optimize the degradation rate and 
mechanical property. However, potential cytotoxicity may be induced by the crosslinking agent’s 
residues. Compared to other crosslinking agents, genipin extracted from the gardenia fruit has 
attracted interest due to its low toxicity. It has been determined that genipin is about 10,000 times 
less cytotoxic than glutaraldehyde to 3T3 fibroblasts [113]. The detailed crosslinking mechanisms 
will be discussed in the next section.  
Fibrin is another promising candidate of the injectable materials and the commercial fibrin 
sealant (Tisseel/Tissucol®) has been widely used for clinical hemostasis. Fibrin is the major 
component of the blood clots, which are biological gels that form through enzymatic crosslinking. 
Fibrin shows great efficacy of promoting neurite outgrowth and neural survival. Von et al. have 
determined that injection of fibrin gel into the cavity after rat spinal cord injury can integrate with 
the host tissue well and promote robust axonal outgrowth [114]. Incorporation of NT-3 into the 
fibrin gels have been demonstrated to promote robust neuronal outgrowth into the lesion site in 
the short term after rat spinal cord injury [115-117]. Fibrin hydrogel can also be modified with 
bioactive peptide domains [118, 119] to deliver and release the supportive cells and neurotrophins 
in a controllable manner. Similar to the collagen gel, fibrin hydrogel is less resistant to degradation 
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and has relatively weak mechanical property [120]. 
Other natural materials including chitosan, alginate and agarose are derived from non-animal 
source and have been widely used in tissue engineering due to the biodegradability, 
biocompatibility, ease of operation and enhanced mechanical property. Due to the non-animal and 
non-ECM origins, unmodified materials may require harsh gelation conditions and usually exhibit 
less intrinsic support for neurite outgrowth and neuronal survival. For example, alginate solution 
can easily form gels in the presence of divalent cations, however, an inhibitory effect on olfactory 
ensheathing glia, Schwann cells and DRG neurons has been demonstrated [121]. Modifications of 
these materials lead to enhanced cell adhesive and mild gelation process. For example, water 
soluble chitosan can be copolymerized with poly-L-lysine [122] and ionic crosslinking can be 
induced by β-glycerol phosphate [123]. Alginate has been covalently coupled with RGD peptide 
to improve the cell binding properties and alginate-RGD gels containing the supportive cells have 
shown significant enhancement of neuronal survival and neurite outgrowth [124, 125].  
 
Figure 1.7 Illustration of the injectable hydrogels carrying supportive cells and neurotrophic 
factors. 
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Figure 1.8 Strategies of injectable hydrogels for the PNS and CNS injury. Injectable hydrogels can 
be used as the fillings of the nerve conduits for the PNS injury, especially for large lesion gaps. 
For the CNS injury, gel solution can be directly injected to the cyst to gel in situ and promote 
axonal regeneration.  
1.3.2 Physical vs. Chemical Crosslinking 
Injectable hydrogels in tissue engineering can be classified into physical and chemical gels 
based on their gelation mechanisms [126]. Physical gels can undergo the liquid to gel transition 
triggered by physical stimuli such as temperature, pH, ionic concentration, self-assembly, etc. The 
advantages of physical gels include mild gelation process, no potentially cytotoxic crosslinkers 
involved, and the permissive substrates for cellular and molecular delivery. However, the 
mechanical strength of physical gels is typically weak and the physical gel can degrade easily in 
vivo. Chemical crosslinking generally results from the covalent bonding induced by chemical 
crosslinkers. Chemical gels can provide improved mechanical strength and resistance to 
degradation [105]. Since the residual crosslinkers cannot be effectively washed away prior to the 
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injection and gelation in situ, the crosslinkers should be non-cytotoxic. Table 1.1 has listed the 
gelation mechanism of commmonly injectable materials. In this research, we aim to explore the 
therapeutic potency of physically and chemically crosslinked collagen gels in nerve injury repair. 
Here, we take collagen and collagen-genipin gels for examples to evaluate the usefulness of the 
physical and chemical crosslinking mechanisms. 
The collagen utilized in our project is 4 mg/mL type I rat tail collagen in a 0.1% acetic acid 
solution (Advanced BioMatrix, CA, USA). The collagen solution was neutralized on ice and 
allowed to gel at physiological temperature. The basic units of type I collagen are two α1(I) and 
one α2(I) chains which are highly enriched in the amino acid residues including glycine, proline 
and hydroxylysine. Under physiological conditions, these chains will spontaneously wrap around 
one another to form a unique triple helix structures. Numerous triple helices could twist together 
to induce the fibrous network which supports and promotes neurite extension (Figure 1.9) [127].  
Alternatively, collagen can be covalently crosslinked to enhance the resistance to degradation 
and mechanical strength. The reaction may occur with the amino groups of lysine residues, the 
carboxyl groups or the hydroxyl groups [128]. Genipin extracted from fruits can be applied to 
crosslink the amino groups of the collagen and produce a deep blue colorant which can be used 
for food dyes. A scheme of the crosslinking mechanism between the amino groups and genipin is 
shown in the Figure 1.10 [129]. It has been demonstrated that the covalent bonding can enhance 
the stability of the collagen gels significantly [130]. Moreover, the genipin concentration could 
notably affect the degradability, swelling ratio, crosslinking level, and mechanical strength of 
collagen gels [131-134].  
Table 1.1 Gelation Mechanisms of the Injectable Hydrogels for Nerve Injury Repair 
 Material Gelation Mechanism 
Natural 
Material 
Collagen Thermal/Chemical crosslinking 
Fibrin Enzymatic crosslinking 
MatrigelTM Thermal crosslinking 
Hyaluronic acid Thermal/Chemical/Free radical crosslinking 
Chitosan Ionic/Chemical crosslinking 
Alginate Ionic crosslinking 
Synthetic 
Material 
PEG Chemical/Radiation/Free radical crosslinking 
PVA Thermal/Chemical/Free radical crosslinking 
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Figure 1.9 Structure of the physical collagen gels. Collagen gel is composed of the network of 
numerous triple-helix chains which contain glycine, proline and hydroxylysine. 
 
Figure 1.10 Scheme of the crosslinking mechanism of the collagen-genipin gel. The amino groups 
can be covalently crosslinked by genipin [106]. 
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1.4 In Vitro Studies of Collagen and Collagen-genipin Gels for Nerve Injury Repair 
Studies have shown that physically crosslinked collagen gels can support a wide range of 
cells, including fibroblasts, neural stem/progenitor cells, Schwann cells, olfactory ensheathing 
cells, DRG sensory neurons, etc. [135-140]. Celinda et al. have reported that the neurites of DRG 
explants can extend downwards and penetrate within the 3D collagen gels from the 2D-3D 
interaction surface and the length decreased with the increasing depth into the collagen gel [141]. 
Studies by Bozkurt et al. have shown that the Schwann cells packed within the DRG explants can 
migrate into the oriented 3D collagen sponge and provide guidance for the DRG axons within the 
scaffold [140]. Willits et al. have determined that the neurites of dissociated DRG neurons can 
grow within the collagen gels and that there is a correlation between the gel stiffness and the neurite 
extension [142]. 
Combinational strategy of molecular and cellular therapy in physical collagen gels has also 
been widely investigated to provide the controlled delivery of beneficial factors and promote 
neurite outgrowth. Katelyn et al. has characterized the supportive role of 3D collagen gels in 
neurite outgrowth of the dissociated DRG neurons. However, incorporation of 10 and 100 μg/mL 
laminin within the gel can reduce the neurite outgrowth without impacting the stiffness of the gels 
[143]. Suk et al. cultured neuron-like pheochromocytoma cells (PC12) on collagen gels with or 
without NGF. The results have shown that NGF could be released steadily from the gels to support 
the survival and neuronal differentiation of the PC12 cells [144]. In another study from Gingras et 
al., it has been determined that the addition of 10 ng/mL NGF can promote the neurite outgrowth 
of DRG sensory neurons cultured on the collagen gel [145].  
Most of the biocompatibility studies of the chemical collagen-genipin gels were evaluated 
using the biomaterials in which the unreacted genipin residues have already been rinsed away. 
For example, Sundararaghavan et al. prepared the collagen gels, allowed the gels to crosslink in 
culture medium containing 1 or 10 mM genipin, and then replaced with genipin-free medium. 
The neurites of DRG explants can be directed and improved by the gradient stiffness of the gels 
[131]. It has also shown that the collagen gels crosslinked by 5 mM and 10 mM genipin lead to 
reduced cell survival of L929 fibroblasts compared to the collagen gel only [130]. However, the 
injectable hydrogels cannot be washed prior to the implantation due to the in situ application. 
Studies have demonstrated that mesenchymal stem cells and astrocytes can survive and 
proliferate within the collagen-genipin gels without the wash [131, 146]. Very limited studies 
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have been performed to evaluate the neurite outgrowth of DRG cultured on or within the 
injectable collagen-genipin gels. 
1.5 Objectives 
Injectable hydrogels have drawn great attention for their potential applications to neural tissue 
engineering. The overall goal of this research is to develop injectable collagen and collagen-
genipin hydrogels and evaluate their therapeutic efficacy combining with cellular and molecular 
therapies for in vitro nerve injury repair. The specific objectives of this research are listed as 
follows. 
(1) To synthesize collagen-based gels that are crosslinked either physically or chemically and 
to characterize the gels in terms of gelation properties, swelling and degradation behaviours and 
microstructures. The effect of collagen and genipin concentration on the gel properties will be 
evaluated and the appropriate formulations will be also determined according to the gelation 
behaviours and feasibility for subsequent studies.  
(2) To evaluate the cytotoxicity of the injectable hydrogels to PRSCs in both 2D and 3D 
environments. The influence of collagen and genipin concentration on PRSCs viability will be 
studied and the appropriate formulation will be determined. Cell morphology and viability of 
PRSCs seeded onto and encapsulated within the hydrogels will also be compared.  
(3) To examine the neurite outgrowth of DRG explants and dissociated neurons seeded on the 
surface of collagen and collagen-genipin gels in culture medium enriched with or without NGF. 
The effect of collagen/genipin concentration and NGF as molecular therapy for neurite outgrowth 
will be determined. Neurite length and morphology of DRG explants and neurons in a 2D 
injectable hydrogel system will be compared to assess the role of in vitro cell models for nerve 
injury repair. 
(4) To assess the efficacy of the injectable hydrogel system infiltrated with the PRSCs in the 
neurite outgrowth of DRG explants and dissociated sensory neurons in the 3D environment. The 
influence of collagen/genipin concentration will be determined and the combinational strategy of 
PRSCs and injectable hydrogels for neurite outgrowth in vitro will be evaluated. Moreover, the 
response of different cell models to the injectable hydrogel system will be compared to study the 
cell-cell interactions and axonal structures of sensory neurons. The distinct DRG behaviour in 2D 
and 3D hydrogel system will be studied to lay the groundwork for future in vivo studies.  
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CHAPTER 2  
MATERIALS AND METHODS 
2.1 Hydrogel Preparation 
The desired concentration of collagen gel solution was prepared on ice by mixing rat-tail type 
I collagen solution (4 mg/mL) (Advanced BioMatrix, USA), 10 × Dulbecco’s Modified Eagle’s 
medium (DMEM) (Sigma-Aldrich, Canada) and 1 × DMEM, and neutralized by 1 N NaOH 
(Sigma-Aldrich, Canada) to a pH of 7.0. Gelation of collagen gel was induced by transferring the 
mixture into a 37 °C incubator. To prepare collagen-genipin hydrogel, a stock solution of 20 mM 
genipin (Wako Pure Chemical, Japan) in 1 × phosphate buffered saline (PBS) (Sigma-Aldrich, 
Canada) was prepared freshly before mixing. Prior to gelation, genipin solution was mixed on ice 
with collagen solution, 10 × DMEM, 1 × DMEM and 1 N NaOH to a pH of 7.0. The mixture was 
then allowed to gel at 37 °C. The samples prepared for characterization studies are shown in Table 
2.1. 
2.2 Characterization of Collagen and Collagen-Genipin Hydrogels 
Collagen and collagen-genipin hydrogels were characterized in terms of their rheology, 
swelling property, degradability and morphology in vitro.  
2.2.1 Rheological Test 
Rheological measurements were performed using an AR-G2 rheometer (TA instruments, DE, 
USA) with a cone and plate geometry (40 mm, 2°). Samples shown in Table 2.1 were initially 
prepared on the plate of the rheometer set at 15 °C. 
A time sweep test was carried out to determine the gelation time and gel strength at 37 °C. 
Samples were warmed from 15 to 37 °C in 5 seconds, and the storage modulus (G’) and loss 
modulus (G’’) were obtained by time sweeps over a period of 0 to 300 s with a frequency of 1 Hz 
at a constant of 5 % strain amplitude. G’ and G’’ curves were plotted and the gelation time was 
defined as the crossover point of the G’ and G’’. During the time sweep test, G’ indicated how gel 
strength varied over time.  
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A temperature sweep test was performed to determine the gelation temperature. Samples were 
warmed from 15 to 37 °C at the rate of 1 °C/min, and G’ and G’’ were measured with a frequency 
of 1 Hz at a constant of 5 % strain amplitude. G’ and G’’ curves were plotted and the gelation 
temperature was also defined as the crossover point of the G’ and G’’.  
Table 2.1 Experimental Groups for Characterization Study 
Formulation Abbreviation Number of Samples 
1.5 mg/mL collagen Col 1.5 3 
2 mg/mL collagen Col 2 3 
2.5 mg/mL collagen Col 2.5 3 
2 mg/mL collagen + 0.25 mM genipin Col 2-Gp 0.25 3 
2 mg/mL collagen + 0.5 mM genipin Col 2-Gp 0.5 3 
2 mg/mL collagen + 1 mM genipin Col 2-Gp 1 3 
2 mg/mL collagen + 5 mM genipin Col 2-Gp 5 3 
2.2.2 Swelling Behaviour Test 
Hydrogels shown in Table 2.1 were prepared as previously. After gelation occurred, the 
swelling behaviour was evaluated by immersing the gels in PBS for 24 hours at 37 °C. After 24 
hours, excess PBS was removed with filter paper and the weight of each sample was measured. 
The swelling ratio of the hydrogels was calculated as:  
Swelling ratio = [(WS-W0)/W0] × 100 %................................................................................... (2.1) 
where WS is the wet weight of the swollen hydrogel and W0 is the initial dry weight of the hydrogel 
after lyophilization by FreeZone freeze dry systems (Labconco, USA). 
2.2.3 Degradation Test 
Degradability of collagen and collagen-genipin hydrogels in PBS was determined by 
incubating the samples in PBS at 37 °C. Hydrogels shown in Table 2.1 were prepared as described 
previously and allowed to gel at 37 °C for 5 min. The initial dry weight of the hydrogel was 
obtained immediately after gelation and freeze-drying. At day 1, 7, 15 and 30, the hydrogel was 
removed from PBS, lyophilized and weighed. Degradability of the hydrogels was assessed by the 
percentage of weight remaining, which was calculated by the following equation:  
WR = [(W0-Wt)/W0] × 100 %.................................................................................................... (2.2) 
where WR is the percentage of weight remaining, W0 is the initial dry weight of the sample and Wt 
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is the dry weight of the sample after degradation.  
2.2.4 Gel Morphology  
Scanning electron microscopy (SEM) was employed to study the structure and morphology 
of the hydrogels. Gels shown in Table 2.1 were prepared as previously, frozen in liquid nitrogen 
and then lyophilized overnight. Freeze dried samples were fixed with conductive tape on a metal 
stub, sputter coated with a gold rod under vacuum, and then examined under a Phenom Pure 
desktop SEM (PhenomWorld, Eindhoven, Dutch) at a 15 kV accelerating voltage. The pore size 
and fiber diameter were estimated by ImageJ 1.48TM software (National Institutes of Health, MD, 
USA). 
2.2.5 Statistical Analysis 
Data were reported as mean ± standard error of the mean. Level of significance was calculated 
using one-way analysis of variance (ANOVA), and Tukey’s post-hoc test was applied for multi-
comparisons among the experimental groups. Statistical analyses were performed using GraphPad 
Prism 6.0TM software (GraphPad Software, San Diego, USA). 
2.3 Characterization of Biocompatibility 
2.3.1 Schwann Cell Culture 
PRSCs were isolated from the sciatic nerves of adult male Sprague-Dawley rats euthanized 
with 2 % isoflurane. All materials were purchased sterile or filter sterilized with 0.22 μm filter 
prior to cell culture. Sciatic nerves wrapped in the muscle tissue from the upper dorsal thigh were 
cut and transferred to cold DMEM. After removing all connective tissue under dissecting 
microscope, nerve fragments were incubated with 10 mg/mL collagenase (Sigma-Aldrich, Canada) 
at 37 °C in a 5 % CO2 incubator for 60 min. Homogeneous cell suspension was achieved by 
repeated trituration using a fire-polished Pasteur pipette. PRSCs were centrifuged and cultured in 
DMEM with 10% fetal bovine serum (FBS) (ThermoFisher Scientific, Canada) in a plastic tissue 
culture dish at 37 °C in a 5 % CO2 incubator. Cells were passed at 85-100 % confluence and re-
suspended in DMEM with 10 % FBS. PRSCs from two to five passages were used for the 
Live/Dead assay to determine the biocompatibility of collagen and collagen-genipin hydrogels.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
2.3.2 Gel Preparation and Cell Seeding 
To assess the biocompatibility, PRSCs were seeded either onto, or encapsulated within, the 
hydrogels as shown in Table 2.2. For PRSCs plated on the surface of the gels, hydrogels were 
prepared on the sterile 12-mm round glass coverslips in a 24-well plate and allowed to gel 
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completely at 37 °C. Coverslips were pre-coated with 1 mg/mL poly-L-lysine (PLL) (Sigma-
Aldrich, Canada) to prevent gels from detachment. PRSCs re-suspended in fresh DMEM with 10 % 
FBS were seeded over the hydrogels and tissue culture plate at a density of 40,000 cells/mL, and 
then incubated in culture medium at 37 °C in a 5 % CO2 incubator. For PRSCs encapsulated in the 
gels, cells re-suspended in medium were gently pre-mixed with gel solution on ice at a density of 
40,000 cells/mL and then gelation was induced by warming up to 37 °C. The mixtures were 
incubated in DMEM with 10 % FBS at 37 °C in a 5 % CO2 incubator. Medium was replaced at 24 
h and 48 h. PRSCs were seeded on the PLL-coated coverslips as a positive control. 
Table 2.2 Experimental Groups for Live/Dead Assay 
Formulation 
Number of Samples 
PRSC seeded onto the 
hydrogels 
PRSC encapsulated 
in the hydrogels 
1.5 mg/mL collagen  3 3 
2 mg/mL collagen  3 3 
2.5 mg/mL collagen 3 3 
2 mg/mL collagen + 0.25 mM genipin 3 3 
2 mg/mL collagen + 0.5 mM genipin 3 3 
2 mg/mL collagen + 1 mM genipin 3 3 
2 mg/mL collagen + 5 mM genipin 3 3 
2.3.3 Live/Dead Assay  
Cell viability and morphology were evaluated on day 3 by Live/Dead assay as following 
procedures. Samples were incubated with 1 μM calcein AM and 2 μM propidium iodide (Sigma-
Aldrich, Canada) in DMEM with 10 % FBS for 1 h at 37 °C in a 5 % CO2 incubator. Cells seeded 
onto the gels were imaged under Carl Zeiss Axiovert 100 fluorescent microscope (Carl Zeiss, Jena, 
Germany), while cells encapsulated in the gels were observed under Leica SP5 confocal 
microscope (Leica Microsystems, Wetzlar, Germany). Live cells were indicated by green 
fluorescence while dead cells were shown in red. Cell viability (%) was calculated as:  
Cell viability = [(NL/ (ND+NL)] × 100 %.................................................................................. (2.3) 
where NL is the number of live cells and ND is the number of dead cells. 
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2.3.4 Data Analysis 
Live and dead cells in the images were analyzed and counted by ImageJ 1.48TM software. 
Confocal images for single sample were merged by the z-project plugin of ImageJ prior to the 
counting. Ten random fields of the image for each sample were chosen for calculation. Data were 
reported as mean ± standard error. Statistical significance was assessed by one-way ANOVA 
followed by Tukey’s test or Dunnett’s test performed using GraphPad Prism 6.0TM software. 
2.4 Characterization of In Vitro Neurite Outgrowth Assay 
2.4.1 DRG Explant and Dissociated Neuron Culture 
DRG explants and dissociated neurons were obtained from adult male Sprague-Dawley rats 
euthanized with 2 % isoflurane. The vertebral columns were removed and kept in ice-cold L15 
medium (Sigma-Aldrich, Canada). By cutting vertebral columns and pulling spinal cord, the 
ganglia were transferred to a 10 cm tissue culture dish containing 5 mL L15 medium on ice. Nerve 
roots and all surrounding connective tissue were carefully removed. The DRGs were dissected into 
the DRG explants under a dissecting microscope.  
 Dissociated DRG sensory neurons were prepared from dissected DRG explants by incubating 
in 10 mg/mL collagenase in L15 medium for 90 minutes, and then in 2 mg/mL trypsin for 30 
minutes at 37°C. The sensory neurons were triturated to homogeneity using a fire-polished Pasteur 
pipette with decreasing bore sizes, and then washed in ice-cold L15 medium with 10 % horse 
serum (HS). DRG sensory neurons were centrifuged and re-suspended in DMEM with 10 % HS 
for cell seeding.  
2.4.2 Gel Preparation and Cell Seeding 
For explants and neurons seeded onto the hydrogels as shown in Table 2.3, hydrogels were 
prepared on the PLL-coated sterile coverslips in the 24-well plate on ice and allowed to gel 
completely at 37 °C. Three DRG explants per sample, or neurons at a final density of 10,000 
cells/mL in fresh DMEM with 10% HS, were seeded onto the hydrogels and incubated at 37 °C in 
a 5 % CO2 incubator for 10 days. The culture medium was supplemented with or without 50 ng/mL 
NGF (Sigma-Aldrich, Canada) to assess how NGF affected the neurite outgrowth. The medium 
was replaced after 24 h and every 48 h thereafter. DRG explants or neurons were seeded on 
laminin-coated coverslips as positive control. 
For explants and neurons encapsulated within the hydrogels as shown in Table 2.4, three DRG 
explants per sample or neurons at a final density of 10,000 cells/mL were re-suspended in DMEM 
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with 10 % HS and mixed with gel solutions on ice. With or without the addition of PRSCs at a 
density of 40,000 cells/mL, gel mixtures were incubated in DMEM with 10 % HS at 37 °C in a 
5 % CO2 incubator and allowed to gel completely. The medium was replaced after 24 h and every 
48 h thereafter. DRG explants or neurons were seeded on laminin-coated coverslips as positive 
control. 
2.4.3 Immunocytochemistry 
After 10 days culture, collagen and collagen-genipin gels with explants or dissociated neurons 
were fixed with 4 % paraformaldehyde at room temperature for 20 minutes and rinsed three times 
with PBS. Samples were then blocked with blocking solution (10 % HS, 0.05 % Tween 20 and 1 % 
bovine serum albumin in PBS) for 1 hour at room temperature and treated with the primary 
antibody (rabbit anti-beta III tubulin, Abcam Inc., Canada) diluted 1:500 overnight at 4 °C. After 
washing three times for 30 minutes with 0.05 % Tween 20 in PBS, the secondary antibody (goat 
anti-rabbit IgG Alex Fluor 488, Abcam Inc., Canada) was added and incubated for 1 hour at room 
temperature. Samples were then washed three times for 30 mins with 0.05 % Tween 20 in PBS 
and mounted on coverslips with Fluoromount-G (SouthernBiotech, USA). Cells-plated gels were 
imaged by conventional fluorescent microscopy, while cell-encapsulated gels were examined 
using a confocal microscope.  
2.4.4 Data Analysis 
Images were analyzed and measured with ImageJ 1.48TM software. Neurite outgrowth of 
explants was quantified as the average neurite length and the density of neurites emitting from the 
explant. The neurite density was defined as the number of pixels covered by neurites divided by 
the total number of pixels covered by neurites and explant, which diminished the variation 
resulting from the differences of explant size. Neurite outgrowth of dissociated neurons was 
evaluated in terms of the average neurite length and the percentage of neurite-bearing neurons. 
Data were reported as mean ± standard error. Level of significance was calculated by one-way or 
two-way ANOVA with GraphPad Prism 6.0TM. Tukey’s and Dunnett’s post-hoc tests were applied 
for multiple comparisons among the experimental groups or comparisons with the control group. 
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Table 2.3 Neurite Outgrowth Assay for DRG-plated Hydrogels 
Formulation 
DRG explants  DRG neurons 
Conditions No. Conditions No. 
Laminin-coated coverslips +/- NGF medium 3 +/- NGF medium 3 
1.5 mg/mL collagen +/- NGF medium 3 +/- NGF medium 3 
2 mg/mL collagen +/- NGF medium 3 +/- NGF medium 3 
2.5 mg/mL collagen +/- NGF medium 3 +/- NGF medium 3 
2 mg/mL collagen + 0.25 mM genipin +/- NGF medium 3 +/- NGF medium 3 
2 mg/mL collagen + 0.5 mM genipin +/- NGF medium 3 +/- NGF medium 3 
Table 2.4 Neurite Outgrowth Assay for DRG-encapsulated Hydrogels 
Formulation 
DRG explants DRG neurons  
Conditions No. Conditions No. 
Laminin-coated coverslips +/- PRSC 3 +/- PRSC 3 
1.5 mg/mL collagen +/- PRSC 3 +/- PRSC 3 
2 mg/mL collagen +/- PRSC 3 +/- PRSC 3 
2.5 mg/mL collagen +/- PRSC 3 +/- PRSC 3 
2 mg/mL collagen + 0.25 mM genipin +/- PRSC 3 +/- PRSC 3 
2 mg/mL collagen + 0.5 mM genipin +/- PRSC 3 +/- PRSC 3 
 
 
 
 
 
 
 
 
   27 
CHAPTER 3  
Experimental Results 
3.1 Hydrogel Preparation 
Collagen and collagen-genipin solutions were formulated on ice and incubated at 37 °C until 
gel formation. DMEM was added as the pH indicator to determine the neutralization point as the 
color changed from yellow to red. Figure 3.1 shows the effect of different formulations and time 
on the appearance of the hydrogels. With the increase of collagen concentration, collagen solutions 
(1.5, 2 and 2.5 mg/mL) transformed into intact and firm gels, which appeared from transparent to 
translucent color immediately after gelation occurred. 2 mg/mL collagen crosslinked by different 
concentrations of genipin (0.25, 0.5, 1 and 5 mM) displayed transparent color at 37 °C right after 
gelation as shown in Figure 3.1 (a). After incubation at 37 °C for 24 hours, the presence of genipin 
induced blue colorant. Gel color deepened with increasing the genipin concentration as shown in 
Figure 3.1 (b).  
 
Figure 3.1 Appearance of collagen and collagen-genipin hydrogels obtained: (a) immediately after 
gelation, and (b) after incubation at 37 °C for 24 hours. From left to right: 1.5, 2 and 2.5 mg/mL 
collagen gels and 2 mg/mL collagen containing 0.25, 0.5, 1 and 5 mM genipin, respectively. 
 
 
   28 
3.2 Characterization of Collagen and Collagen-Genipin Hydrogels 
The gelation properties, swelling behaviour, degradability and gel morphology were 
evaluated to compare and characterize the physically and chemically crosslinked hydrogels.  
3.2.1 Gelation Properties 
To determine the gelation time, gelation temperature and gel strength, the storage modulus 
(G’) and loss modulus (G’’) data were obtained in a rheological test. G’ and G’’ curves were plotted 
to investigate the viscoelastic properties of collagen and collagen-genipin hydrogels.  
Figure 3.2 shows an example of rheological data of 2 mg/mL collagen (Col 2) hydrogel. 
Figure 3.2 (a) (b) display the G’ and G’’ curves of the time sweep test ranging from 0 to 300 s at 
37 °C. G’ and G’’ showed a tendency to increase and crossed at a point indicating gel formation. 
After gelation occurred, G’ became larger than G’’ and reached a plateau. Gel strength (G’) of the 
plateau was recorded at 300 s. Figure 3.2 (c) (d) show the G’ and G’’ curves of the temperature 
sweep test ranging from 15 to 37 °C and the crossover point represents the gelation temperature. 
Gelation time as determined by the method described above is shown in Figure 3.3 (a). The 
gelation time of physically crosslinked collagen gels (1.5, 2 and 2.5 mg/mL) was 35.8 ± 0.8, 32.5 
± 1.1 and 27.3 ± 0.8 s, respectively. One-way ANOVA showed collagen concentration affected the 
gelation time significantly. Tukey’s test showed significant differences except between Col 1.5 and 
Col 2. For collagen-genipin gels, one-way ANOVA demonstrated no significant effect of genipin 
concentration on gelation time when compared to 2 mg/mL collagen. 
Figure 3.3 (b) shows the determination of gelation temperature. The gelation temperature of 
1.5, 2 and 2.5 mg/mL collagen gels was 32.5 ± 0.4, 31.0 ± 0.5 and 29.5 ± 0.5 °C, respectively. 
Gelation temperature decreased with increasing collagen concentration. One-way ANOVA 
indicated a significant effect of collagen concentration on gelation temperature. Tukey’s post-hoc 
test determined that there was a significant difference of gelation temperature between 1.5 and 2.5 
mg/mL collagen gels. The gelation temperature of 2 mg/mL collagen crosslinked by the highest 
concentration of genipin (5 mM) was 30.8 ± 0.7 °C. Statistically, there was no significant effect of 
genipin concentration on gelation temperature when compared to 2 mg/mL collagen. 
Gel strength represented by G’ was obtained in the time sweep test at 300 s. As shown in 
Figure 3.3 (c), the gel strength of 1.5, 2 and 2.5 mg/mL collagen gels was 39.7 ± 1.3, 43.9 ± 2.1 
and 54.3 ± 4.1 Pa, respectively. Gel strength increased with increasing collagen concentration. 
One-way ANOVA demonstrated the significant effect of collagen concentration on gel strength. 
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For collagen-genipin gels, the gel strength of Col 2-Gp 5 was 58.9 ± 1.7 Pa with an increase of 
34 % when compared to Col 2. Genipin concentration has a significant effect on the gel strength 
at 300 s as determined by one-way ANOVA.  
 
Figure 3.2 Examples of rheological data of 2 mg/mL collagen hydrogel: (a) Time sweep test 
ranging from 0-300 s at 37 °C, a constant 5 % strain and a frequency of 1 Hz; (b) Close-up view 
of the crossover point of G’ and G’’ in the time sweep test; (c) Temperature sweep test ranging 
from 15-37 °C at a 5 % strain and a frequency of 1 Hz; (d) Close-up view of the crossover point 
of G’ and G’’ in the temperature sweep test. 
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Figure 3.3 Results of the rheological test of collagen and collagen-genipin hydrogels: (a) Gelation 
time at 37 °C; (b) Gelation temperature; (c) Gel strength (G’) at 300 s. Error bars stand for standard 
error. n=3, *p<0.05, **p<0.01, ***p<0.0001. 
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3.2.2 Swelling Ratio  
To investigate the swelling behaviour of physically and chemically crosslinked gels in PBS, 
the swelling ratio was calculated and shown in Figure 3.4. The swelling ratio of collagen gels (1.5, 
2 and 2.5 mg/mL) was 1116 ± 33, 818 ± 48 and 698 ± 26 %, respectively. Swelling ratio decreased 
with the increase of collagen concentration. One-way ANOVA demonstrated the significant effect 
of collagen concentration on the swelling behaviour. Compared to Col 2, the addition of genipin 
(0.25, 0.5, 1 and 5 mM) led to a decrease of the swelling ratio: 664 ± 49, 724 ± 44, 529 ± 45 and 
464 ± 22 %, respectively. A statistically significant effect of genipin concentration on the swelling 
ratio was determined. In the presence of 1 and 5 mM genipin, swelling ratios were significantly 
reduced from the value of 2 mg/mL collagen gel.  
 
Figure 3.4 Swelling ratio of collagen and collagen-genipin hydrogels immersed in PBS for 24 h 
at 37 °C. Error bars stand for standard error. n=3, *p<0.05, **p<0.01, ***p<0.0001. 
3.2.3 Degradation Study 
Collagen is regarded to be one of the most promising natural biomaterials, however its rapid 
degradation in vivo limits its application. Therefore, how to optimize the degradation property 
should be considered. In this study, degradation experiments were performed to evaluate the effects 
of the physical and chemical crosslinking mechanisms induced by temperature and genipin, 
respectively, on degradation behaviour. Degradability was assessed by the weight remaining ratio 
(%) obtained on day 1, 7, 15 and 30 after incubation in PBS. The results are presented in Figure 
3.5. 
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After immersion in PBS for 1 day, the weight remaining ratios of collagen gels (1.5, 2 and 
2.5 mg/mL) was 91 ± 2.4, 92 ± 1.3 and 95 ± 2.7 %, and the value for 2 mg/mL collagen crosslinked 
by the highest concentration of genipin (5 mM) was 96 ± 1.6 %. One-way ANOVA revealed no 
significant differences among all experimental groups.   
On day 7, the weight remaining ratios of collagen gels (1.5, 2 and 2.5 mg/mL) decreased to 
80 ± 2.3, 88 ± 2.2 and 92 ± 1.3 %, respectively. Weight remaining ratio of collagen gels increased 
with increasing collagen concentration. One-way ANOVA confirmed the significant effect of 
collagen concentration on degradation behaviour of the physically crosslinked gels. There was no 
significant difference between 2 mg/mL collagen and 2 mg/mL collagen crosslinked by genipin 
(0.25-5 mM).  
On day 15, the percentage of weight remaining for collagen gels (1.5, 2 and 2.5 mg/mL) was 
71 ± 4.4, 74 ± 2.6 and 85 ± 0.9 %, respectively. Resistance to degradation was enhanced with 
increasing the collagen concentration. The weight remaining of collagen-genipin gels ranged from 
81 ± 1.1 (0.25 mM) to 88 ± 2.2 % (5 mM). Compared to Col 2, significant difference between Col 
2 and Col 2-Gp 5 was indicated by Tukey’s test. One-way ANOVA determined the significant 
effect of collagen concentration on degradation behaviour. On the contrary, there was no 
significant effect of genipin concentration on degradability. 
The weight remaining of 2 mg/mL collagen was reduced from 92 ± 1.3 % on day 1 to 55.3 ± 
1.0 % on day 30, whereas the weight remaining ratio of 2 mg/mL collagen crosslinked by highest 
concentration of genipin changed from 96 ± 1.6 % on day 1 to 77 ± 1.9 % on day 30. Two-way 
ANOVA demonstrated significant effects of collagen concentration and degradation time on 
degradation behaviour of collagen gels. Compared to 2 mg/mL collagen gel only, the weight 
remaining ratio increased significantly with the presence of genipin, whereas no significant effect 
of genipin concentration was indicated statistically. 
The results indicated that the weight remaining ratio increased significantly as increasing 
collagen concentration. Compared to the 2 mg/mL collagen only, crosslinking induced by genipin 
can improve the resistance to degradation of collagen gels in PBS starting from day 15 to day 30. 
However, genipin concentration had no significant effect on degradation behaviour in PBS at a 
period of 30 days.  
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Figure 3.5 Weight remaining ratio of collagen and collagen-genipin hydrogels incubated in PBS 
for 1, 7, 15 and 30 days. Error bars stand for standard error. n=3. 
3.2.4 Gel Morphology  
To evaluate the morphology and inner-structure of collagen and collagen-genipin hydrogels, 
cross-sections of the lyophilized gels were exposed and observed under SEM microscope (Figure 
3.6).  
SEM images (Figure 3.6 (a-c)) of physically crosslinked collagen gels exhibit fibrous and 
porous structures with the average pore size of 3.3 μm and fiber diameter of 230 nm, approximately. 
There was no obvious effect of collagen concentration on the pore size or fiber diameter. However, 
with the increase of collagen concentration, the portion of porous network decreased slightly.  
Figure 3.6 (d-g) displays the SEM images of chemically crosslinked collagen-genipin gels. 
Comparing with the SEM image of 2 mg/mL collagen gel only (Figure 3.6 (b)), hydrogels 
containing high concentration of genipin exhibited a very dense fibrillary network. In the presence 
of 0.25 mM genipin, the average pore size decreased to 1.5 μm and the fiber diameter was reduced 
to 160 nm, approximately. With the increase of genipin concentration, the pore structure 
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diminished slightly and the fiber diameter remained at a similar level. Collagen hydrogel 
crosslinked by 5 mM genipin aggregated and collapsed to very dense fibrillary clusters and few 
pore structures were observed. With the addition of genipin, the shrinkage of the porous structure 
shown in the SEM images correlated with the results of the swelling behaviour. 
 
Figure 3.6 SEM images of the cross-section area of collagen and collagen-genipin hydrogels:   
(a-c) 1.5, 2 and 2.5 mg/mL collagen gels; (d-g) 2 mg/mL collagen gels crosslinked by 0.25, 0.5, 1 
or 5 mM genipin, respectively. 
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3.3 Biocompatibility 
The long-term strategy for this project is to produce a gel with a permissive environment for 
infiltrated supportive cells to bridge the injured site and promote axonal regeneration. PRSCs are 
one of the most promising candidates for cell transplantation in the application of nerve injury 
repair. To evaluate the biocompatibility of PRSCs on 2D or 3D environment in vitro, PRSCs were 
seeded onto the surface or encapsulated within the collagen and collagen-genipin gels, and then 
cultured for 3 days. Biocompatibility was evaluated by two parameters: cell viability and cell 
morphology.  
3.3.1 Schwann Cell Culture 
PRSCs cultured on tissue culture plate served as positive control. After 3 days culture, PRSCs 
displayed typical spindle-like morphology and the majority of the cells were alive indicated by 
green fluorescent in the Live/Dead assay as shown in Figure 3.7 (a) and Figure 3.9 (a). 
3.3.2 Biocompatibility of Cell-plated Hydrogels 
PRSCs were seeded onto the preformed collagen and collagen-genipin gels and cultured for 
3 days. Cell viability and morphology were evaluated by Live/Dead assay and observed by 
fluorescence microscopy.  
As shown in Figure 3.7 (b-d), PRSCs cultured on physically crosslinked collagen gels 
exhibited spindle-like morphology. Figure 3.8 shows that the cell viability of the positive control 
and the collagen gels of 1.5, 2 and 2.5 mg/mL was 98 ± 0.7, 96 ± 0.8, 84 ± 1.4 and 85 ± 2.0 %, 
respectively. One-way ANOVA determined that there was a significant difference of cell viability 
between the positive control and collagen gels. Comparing to the tissue culture plate, collagen 
concentration had a significant effect on PRSCs viability as indicated. Cell viability decreased with 
increasing collagen concentration.  
For chemically crosslinked gels, the majority of surviving PRSCs seeded onto the Col 2-Gp 
0.25 and Col 2-Gp 0.5 gels displayed spherical (Figure 3.7 (e) and (f)). However, very few viable 
PRSCs were observed on 2 mg/mL collagen gels crosslinked by higher concentrations of genipin 
(1 or 5 mM) and all surviving cells exhibited a spherical shape, which indicated high cytotoxicity 
and non-favorable environment for PRSCs (Figure 3.7 (g) and (h)). Cell viability of PRSCs seeded 
on 2 mg/mL collagen gels crosslinked by 0.25 and 0.5 mM genipin was 68 ± 1.2 and 62 ± 1.4 %, 
with a decrease of 19 % and 26 % when compared to 2 mg/mL collagen gel.  
To summarize, PRSCs seeded onto 1.5 mg/mL collagen gels had the highest cell viability 
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among all experimental groups and exhibited typical spindle-like morphology. Compared to the 
chemically crosslinked collagen-genipin gels, physically crosslinked collagen gels provided more 
favorable environment possibly resulting from the adhesive property of collagen. The Live/Dead 
assay indicated that high concentrations of genipin (1 or 5 mM) inhibited the cell viability of 
PRSCs significantly. 
 
Figure 3.7 Live/Dead staining of rat PRSCs cultured on the surface of collagen and collagen-
genipin hydrogels for 3 days: (a) tissue culture plate; (b-d) 1.5, 2 and 2.5 mg/mL collagen gels; (e-
h) 2 mg/mL collagen gels crosslinked by 0.25, 0.5, 1 and 5 mM genipin, respectively. Green and 
red fluorescence indicate live and dead PRSCs, respectively. Scale bar=100 μm. 
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Figure 3.8 Cell viability of rat PRSCs cultured on different surfaces for 3 days. * indicates a 
statistically significant difference when compared to the control group (tissue culture plate). n=3, 
*p<0.05, **p<0.01, ***p<0.0001. Error bars stand for standard error.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
3.3.3 Biocompatibility of Cell-encapsulated Hydrogels 
PRSCs were mixed with the gel solution thoroughly on ice and transferred to a 37 °C 
incubator immediately, preventing cells from sinking to the glass bottom, and were then cultured 
for 3 days. Cell viability and morphology were evaluated by Live/Dead assay and observed under 
a confocal microscope. Figure 3.9 shows the max-intensity stacks of confocal images. PRSCs 
cultured on tissue culture plate served as positive control as shown in Figure 3.9 (a). 
After cultured for 3 days, PRSCs encapsulated into 1.5, 2 and 2.5 mg/mL collagen gels 
displayed typical spindle shape as shown in Figure 3.9 (a-c). Cell viability within the collagen gels 
(1.5, 2 and 2.5 mg/mL) was 95 ± 1.4, 89 ± 1.0 and 81 ± 1.7 %, respectively. Cell viability decreased 
with increasing collagen concentration. Comparing to the tissue culture plate, one-way ANOVA 
determined that there was a significant effect of collagen concentration on cell viability. There was 
a strong correlation of cell viability of PRSCs either seeded onto or encapsulated within the 
physically crosslinked collagen gels. 
For collagen-genipin gels, cell viability of PRSCs encapsulated within 2 mg/mL collagen gel 
crosslinked by 0.25 mM genipin was 71 ± 2.1 %, with a decrease of 27 % and 20 % comparing to 
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the viability of tissue culture plate and 2 mg/mL collagen gels, respectively. The majority of 
surviving cells exhibited spherical as shown in Figure 3.9 (d). Very few PRSCs survived within 2 
mg/mL collagen gels crosslinked by 0.5 mM genipin and all cells were dead in 2 mg/mL collagen 
gels crosslinked by higher concentration of genipin. One-way ANOVA indicated a significant 
effect of genipin concentration on cell viability. Significant differences of cell viability for 
collagen-genipin gels were also determined when compared to the positive control group or 2 
mg/mL collagen gel only.  
These results demonstrated that PRSCs were less tolerant to 3D environment with the 
presence of genipin. Physically crosslinked collagen gels showed higher cell viability than 
collagen-genipin gels either in 2D or 3D experiments. Due to the cytotoxicity of high concentration 
genipin confirmed by 2D and 3D Live/Dead assays, 0.25 and 0.5 mM genipin were applied for the 
following studies.   
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Figure 3.9 Live/Dead staining of rat PRSCs encapsulated within collagen and collagen-genipin 
hydrogels cultured for 3 days: (a-c) 1.5, 2 and 2.5 mg/mL collagen gels; (d-g) 2mg/mL collagen 
gels crosslinked by 0.25, 0.5, 1 and 5 mM genipin, respectively. Green and red fluorescence 
indicate live and dead PRSCs, respectively. Scale bar=50 μm. 
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Figure 3.10 Cell viability of rat PRSCs cultured within collagen and collagen-genipin gels for 3 
days. * indicates a statistical difference when compared to the control group (tissue culture plate). 
n=3, *p<0.05, **p<0.01, ***p<0.0001. Error bars stand for standard error. 
3.4 DRG Explants and Dissociated Neurons Culture 
DRG explant and dissociated DRG sensory neuron are excellent in vitro models to explore 
the mechanisms of axonal regeneration and evaluate the potentially therapeutic effect of the 
hydrogels. DRG explant is a cluster of sensory neurons and other supporting cells. The unique 
advantage of the DRG explant model is that it can simulate the original state in vivo and preserve 
the original cell components in DRGs and the cell-cell interactions, which are lost in the 
dissociated DRG neuron model. Mature DRG sensory neuron exists in a pseudo-unipolar form in 
vivo. Mostly bipolar and rarely multipolar morphology are also present in developing DRG sensory 
neurons in vivo. In a favorable culture environment, DRG neurons can grow neurites. Long 
processes can differentiate into axons, whereas other short neurites can differentiate into dendrites. 
Comparing with the DRG explant model, dissociated DRG neuron model offers a better 
opportunity to visualize how the gels affect the regeneration of individual neurite of sensory neuron 
while still minimizing other influences. However, dissociation entails greater disruption of normal 
cell-cell interactions. 
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3.4.1 DRG Explant Culture 
DRG explants were dissected from the DRGs and the average dimeter of each explant ranged 
from 600 to 900 μm. DRG explants were evaluated immunohistochemically. Figure 3.11 shows 
the images obtained immediately after dissection to evaluate the originally cellular structure of 
DRG explants. Green staining (Figure 3.11 (a) (d)) indicated neuronal soma and neurites, while 
red staining (Figure 3.11 (b) (e)) indicated PRSCs. As shown in Figure 3.11, DRG explants were 
composed of sensory neurons and PRSCs. Some resident macrophages were also likely present, 
but not visualized in these preparations. Since PRSCs play important roles as myelination of axons, 
trophic support for neurons, etc., they were found widely distributed within and around the explant. 
Figure 3.11 (c) (e) show the merged staining images indicating the preserved relationship between 
sensory neurons and PRSCs.  
DRG explants were cultured in DMEM/10 % HS for 10 days on laminin-coated coverslips as 
the control group. Since explants could easily detach from the laminin-coated coverslips during 
the culture and staining process, careful handling and multiple explants were needed. Figure 3.12 
(a) shows the image of a DRG explant cultured on laminin-coated coverslips after 10 days culture. 
It was shown that a few neurites elongating from the explant. 
3.4.2 DRG Dissociated Neuron Culture 
DRG neurons were dissociated from the DRG explants and re-suspended in fresh medium. 
Neurons were observed under a fluorescence microscope and displayed spherical and smooth 
morphology prior to cell culture. DRG neurons were then seeded on laminin-coated coverslips as 
a control. Following culture in DMEM/10 % HS for 10 days, neurite outgrowth was stained 
immunohistochemically using β-III tubulin antibody. As shown in Figure 3.12 (b), neurite 
regeneration and abundant neurite structures were observed. The majority of neurons with neurites 
exhibited multipolar morphology. 
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Figure 3.11 Immunofluorescent staining of DRG explant obtained immediately after dissection: 
(a-c) 10 x magnifications of explant stained by β-III tubulin, S-100 and merged image, respectively; 
(d-f) 20 x magnifications of explant stained by β-III tubulin for neurons (green), and S-100 for 
PRSCs (red), and merged images. Scale bar=100 μm. 
 
Figure 3.12 Immunofluorescent staining of a DRG explant (a) and a dissociated neuron (b) cultured 
on laminin-coated coverslips for 10 days. Scale bars are indicated in the images. 
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3.5 Neurite Outgrowth Assay for DRG-plated Hydrogels 
Explants and dissociated neurons were seeded onto the hydrogels to evaluate: the effect of 
collagen and collagen-genipin gels on neurite outgrowth; the differences of the neurite outgrowth 
in two different models in vitro; and the response of DRG to NGF. 
3.5.1 Neurite Outgrowth of DRG Explants Seeded onto the Hydrogels 
DRG explants were seeded onto the hydrogels and cultured for 10 days to assess whether 
collagen and collagen-genipin gels could provide favorable environment for neurite regeneration 
following injury. 50 ng/mL NGF was also added to the culture medium in some cultures to evaluate 
the response of DRG explants to NGF.  
After 10 days culture, DRG explants were stained immunohistochemically using β-III tubulin 
antibody and the regenerated neurites were visualized as shown in Figure 3.13. Neurite outgrowth 
was quantified as the average neurite length (μm) and neurite density (%). DRG explants were 
cultured on laminin-coated coverslips with (+) or without (-) NGF-conditioned medium as the 
control groups. 
Figure 3.13 shows the immunofluorescent images of DRG explants seeded onto the gels with 
or without NGF in the culture medium. Control group (+) and experimental groups (+) cultured in 
DMEM/10 % HS/NGF displayed substantially denser and longer neurites scattering from the 
explants when compared to those cultured in medium without NGF (-). For the collagen gels, DRG 
explants seeded onto 2.5 mg/mL collagen gel exhibited the most neurite extension and neurite 
branches under both conditions as shown in Figure 3.13 (g) and (h). For the collagen-genipin gels, 
the neurite extension and the length of sprouting neurites from the explants seeded onto Col 2-Gp 
0.25 and Col 2-Gp 0.5 were significantly reduced when cultured in NGF free medium (Figure 3.13 
(i) and (k)). With the addition of NGF to the medium, the neurite outgrowth of the explants seeded 
onto the collagen-genipin gels was enhanced greatly (Figure 3.13 (j) and (l)).  
To further elucidate how the gels and NGF affected the neurite outgrowth, the results of 
quantification analysis were shown in Figure 3.14. The average neurite length of the control group 
cultured in medium without or with NGF was 580 ± 53 and 863 ± 45 μm, and the neurite density 
was 14 ± 2.5 and 75 ± 3.3 %, respectively.    
For explants cultured in NGF-free medium (-), 2.5 mg/mL collagen gel had the highest 
average neurite length of 935 ± 39 μm and neurite density of 77 ± 2.9 %, which was increased by 
61 % and 63 % comparing with the control group (-). For collagen gels only (-), one-way ANOVA 
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determined that the effect of collagen concentration on the average neurite length and neurite 
density was significant. The average neurite length for Col 2.5 was higher than Col 1.5 and Col 2, 
while Tukey’s test showed no significant difference of the average neurite length between Col 1.5 
and Col 2. Statistically, the neurite density increased greatly with increasing collagen concentration. 
For collagen-genipin gels (-), there was no significant difference of the average neurite length 
among Col 2, Col 2-Gp 0.25 and Col 2-Gp 0.5. The neurite density decreased significantly with 
the presence of genipin, whereas there was no significant difference between Col 2-Gp 0.25 and 
Col 2-Gp 0.5 as determined by Tukey’s post-hoc test. 
 For explants cultured in NGF-conditioned medium (+), 2.5 mg/mL collagen gel had the 
highest average neurite length of 1326 ± 83 μm and neurite density of 85 ± 3.6 %, which was 
increased by 54 % and 9 % comparing with the control group (+), respectively. For collagen gels 
only, the average neurite length and neurite density increased with the increase of collagen 
concentration. One-way ANOVA determined that there was a significant effect of collagen 
concentration on the average neurite length and neurite density. For collagen-genipin gels, one-
way ANOVA determined that there was a significant effect of genipin concentration on the average 
neurite length among Col 2, Col 2-Gp 0.25 and Col 2-Gp 0.5. The neurite density decreased 
noticeably with the increase of genipin concentration, while no significant difference between Col 
2 and Col 2-Gp 0.25 was seen using Tukey’s test. 
Quantitative results confirmed that NGF-conditioned medium enhanced both the average 
neurite length and neurite density significantly. 2.5 mg/mL collagen gel provided the most 
favorable environment for the neurite outgrowth of DRG explants among all the groups in both 
conditions. Two-way ANOVA determined that NGF and collagen concentration had significant 
effects on the neurite outgrowth among collagen gels. Also, the neurite outgrowth of explants 
seeded on collagen-genipin gels were significantly affected by the presence of NGF and genipin 
concentration.   
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Figure 3.13 Immunofluorescent staining of DRG explants cultured on the collagen and collagen-
genipin gels for 10 days in DMEM/10 % HS medium enriched with (+) or without (-) NGF. From 
top to bottom: (a-b) Control groups: DRG explants on laminin-coated coverslips; (c-d) Explants 
on 1.5 mg/mL collagen hydrogels; (e-f) Explants on 2 mg/mL collagen hydrogels; (g-h) Explants 
on 2.5 mg/mL collagen hydrogels; (i-j) Explants on 2 mg/mL collagen hydrogels crosslinked by 
0.25 mM genipin; (k-l) Explants on 2 mg/mL collagen hydrogels crosslinked by 0.5 mM genipin. 
Scale bar=1000 μm 
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Figure 3.14 Quantitative analysis of neurite outgrowth of DRG explants cultured on the surface of 
collagen and collagen-genipin gels in DMEM/10 % HS medium conditioned with (+) or without 
(-) NGF for 10 days: (a) Average neurite length per explant (μm, n=3); (b) Neurite density (%, 
n=3), is defined as the number of pixels covered by neurites divided the total number of pixels 
covered by neurites and explant. *p<0.05, **p<0.01, ***p<0.0001 when compared to the control 
group cultured in culture medium without NGF. #p<0.05, ##p<0.01, ###p<0.0001 when compared 
to the control group cultured in NGF-conditioned medium. Error bars stand for standard error. 
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3.5.2 Neurite Outgrowth of DRG Neurons Seeded onto the Hydrogels 
To assess the effect of NGF-conditioned medium and different substrates on the neurite 
regeneration of sensory neurons, DRG dissociated neurons were seeded onto the collagen and 
collagen-genipin gels and cultured in medium with (+) or without (-) NGF. Figure 3.15 shows the 
morphology of the sensory neurons and the results of quantitative analysis were displayed in 
Figure 3.16.  
DRG neurons cultured on laminin-coated coverslips exhibited abundant neurite outgrowth as 
shown in Figure 3.15 (a). Comparing with the control group (-), neurons seeded onto 2 and 2.5 
mg/mL collagen gels (-) exhibited longest growth among all experimental groups (-). Connections 
between neurons were observed on 2.5 mg/mL collagen gel (Figure 3.15 (g)). For collagen-genipin 
gels (-), the length of regenerated neurites was reduced significantly and few neurons with very 
short neurites were observed for Col 2-Gp 0.5 mM genipin (-) as shown in Figure 3.15 (k).  
With the addition of NGF in the culture medium (+), longer growth and more neurite-bearing 
neurons were observed among all groups. As shown in Figure 3.15 (d), (f) and (h), the number of 
branching process decreased with increasing collagen concentration. DRG neurons seeded onto 
1.5 mg/mL collagen gel (+) exhibited more short neurites comparing with other experimental 
groups (+). The average neurite length of collagen-genipin gels (+) decreased considerably when 
compared to the collagen gel only (+) as shown in Figure 3.15 (j) and (l). 
As shown in Figure 3.16, the average neurite length of neurons cultured in medium (-/+ NGF) 
was 407 ± 23 and 762 ± 45 μm, and the percentage of neurite-bearing neurons was 36 ± 1.4 and 
43 ± 0.5 %, respectively.  
For neurons cultured in NGF-free medium, statistical differences of the average neurite length 
(μm) and the percentage of neurite-bearing neurons (%) between the control group (-) and 
experimental groups (-) were found. For collagen gels, the average neurite length of neurons 
cultured on 1.5 mg/mL collagen gel (-) decreased significantly when compared to the control group 
(-), whereas there was no significant differences of the neurite length among the control (-), Col 2 
(-) and Col 2.5 (-). The percentage of neurite-bearing neurons seeded on collagen gels was reduced 
by 40 % when compared to the control group (-), and collagen concentration had no significant 
effect on the result. For collagen-genipin gels, one-way ANOVA determined the significant effect 
of genipin concentration on the neurite outgrowth when compared to 2 mg/mL collagen. The 
average neurite length and percentage of neurite-bearing neurons was reduced significantly with 
   48 
increasing genpin concentration.  
For neurons cultured in NGF-containing medium, NGF enhanced both the average neurite 
length and the ratio of neurite-bearing neurons significantly. There was a significant difference of 
the neurite outgrowth between the control group (+) and experimental groups (+). One-way 
ANOVA determined collagen concentration had a significant effect on the average neurite length, 
and average neurite length increased with increasing collagen concentration. Thus, both NGF and 
collagen concentration had significant effects on the average neurite length and the percentage of 
neurite-bearing neurons for collagen gels. In the presence of genipin, the average neurite length 
reduced significantly with increasing genipin concentration. There was no significant difference 
of the percentage of neurite-bearing neurons among all the experimental groups. Two-way 
ANOVA showed that there were significant effects of NGF and genipin concentration on the 
neurite outgrowth among Col 2, Col 2-Gp 0.25 and Col 2-Gp 0.5 (-/+). 
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Figure 3.15 Immunofluorescent staining of dissociated DRG neurons cultured on the collagen and 
collagen-genipin gels for 10 days in DMEM/10 % HS medium enriched with (+) or without (-) 
NGF: (a-b) DRG neurons cultured on laminin-coated coverslips; (c-d) DRG neurons cultured on 
1.5 mg/mL collagen hydrogels; (e-f) DRG neurons cultured on 2 mg/mL collagen hydrogels; (g-
h) DRG neurons cultured on 2.5 mg/mL collagen hydrogels; (i-j) DRG neurons cultured on 2 
mg/mL collagen hydrogels crosslinked by 0.25 mM genipin; (k-l) DRG neurons cultured on 2 
mg/mL collagen hydrogels crosslinked by 0.5 mM genipin. Scale bar=200 μm. 
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Figure 3.16 Quantitative analysis of neurite outgrowth of dissociated DRG neurons cultured onto 
the collagen and collagen-genipin gels for 10 days in DMEM/10 % HS medium conditioned with 
(+) or without (-) NGF: (a) Average neurite length per neuron (μm, n=10); (b) Percentage of 
neurite-bearing neurons (%, n=3). *p<0.05, **p<0.01, ***p<0.0001 when compared to the control 
group cultured in medium without NGF. #p<0.05, ##p<0.01, ###p<0.0001 when compared to the 
control group cultured in NGF-conditioned medium. Error bars stand for standard error. 
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3.6 Neurite Outgrowth Assay for DRG-encapsulated Hydrogels 
3D hydrogels more closely mimicked the environment in vivo, therefore incorporation of 
explants or neurons into the gels was performed to evaluate: the effect of collagen and collagen-
genipin gels on neurite outgrowth; the neurite outgrowth of two different models in vitro; and the 
effect of gels enriched with PRSCs on neurite outgrowth.  
3.6.1 Neurite Outgrowth of DRG Explants Encapsulated in the Hydrogels 
To evaluate whether incorporation of PRSCs within the injectable hydrogels would enhance 
neurite outgrowth, explants were encapsulated within the collagen and collagen-genipin gels 
enriched with or without PRSCs and cultured for 10 days in DMEM/10 % HS. After 10 days 
culture, DRG explants were stained immunohistochemically and observed under confocal 
microscopy. DRG explants were cultured on laminin-coated coverslips with or without PRSCs as 
the control groups (Figure 3.17 (a-b)).  
Figure 3.17 shows immunofluorescent images of DRG explants encapsulated within the gels 
with (+) or without (-) supplementary PRSCs. In all conditions, neurites grew and extended from 
the explants within the hydrogels. For explants cultured in collagen gels without PRSCs (-), neurite 
outgrowth was enhanced with increasing collagen concentration (Figure 3.17 (c), (e) and (g)). 
Neurite length and neurite density increased dramatically when PRSCs were also incorporated 
within (+). Comparing with the 2 mg/mL collagen gel, fewer and shorter neurites were observed 
in the presence of 0.25 or 0.5 mM genipin in both conditions as shown in Figure 3.17 (i-l).  
Figure 3.18 (b) and (d) display the representative 3D reconstruction images from stacked 
confocal images of neurite regeneration in 2 mg/mL collagen gel. It was shown that DRG neurites 
could penetrate and grow within the gels and that neurite outgrowth was enhanced significantly 
with the addition of PRSCs.  
Quantitative analysis of neurite outgrowth was defined as the average neurite length (μm) and 
the neurite density (%). The average neurite length in 3D gels was measured by the tracing tools 
in ImageJ. Neurite density was calculated by the max stack images of the confocal images. 
Quantitative assessment of neurite outgrowth within the injectable hydrogels was shown in Figure 
3.19.  
For hydrogels containing no supplementary PRSCs (-), the average neurite length within a 2 
mg/mL collagen gel was 324 ± 32 μm, with a decrease of 38 % comparing with the control group 
(-). One-way ANOVA showed no significant effect of collagen concentration on the average 
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neurite length. The neurite density of 2 mg/mL collagen gel was 15 ± 1.9 %. No statistically 
significant difference in neurite density was observed among the control group (-), Col 1.5, Col 2 
and Col 2.5. For collagen-genipin gels, the average neurite length of Col 2-Gp 0.25 and Col 2-Gp 
0.5 decreased by 55 % and 42 % when compared to the control group (-). The presence of genipin 
had no significant effect on the average neurite length comparing with 2 mg/mL collagen gel. With 
the addition of genipin, the neurite density of collagen-genipin gels decreased significantly when 
compared to 2 mg/mL collagen gel only. 
For hydrogels enriched with supplementary PRSCs, the average neurite length and neurite 
density for Col 2 were 509 ± 25 μm and 36 ± 1.9 %. Comparing to the control group (+), both the 
average neurite length and neurite density for Col 2.5, Col 2-Gp 0.25 and Col 2-Gp 0.5 were 
significantly reduced, whereas there was no significant difference among the control, Col 1.5 and 
Col 2. When compared to the 2 mg/mL collagen gel only, 0.25 and 0.5 mM genipin had a 
significantly negative effect on: the average neurite length with a decrease of 48 % and 28 %; and 
the neurite density with a decrease of 27 % and 21 %. Quantitative analysis determined that the 
neurite regeneration within the hydrogels supplemented with PRSCs was enhanced significantly.  
For collagen gels, two-way ANOVA determined PRSCs had a significant effect on the 
average neurite length and neurite density, whereas collagen concentration only had a significant 
effect on the neurite density. For collagen-genipin gels, PRSCs and genipin concentration had 
significant effects on both the average neurite length and neurite density. 
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Figure 3.17 Confocal microscopy of DRG explants encapsulated and cultured within the collagen 
and collagen-genipin gels for 10 days. - indicates DRG explants only and + represents DRG 
explants and supplementary PRSCs. From top to bottom: (a-b) Explants cultured on laminin-
coated coverslips; (c-d) Explants encapsulated in 1.5 mg/mL collagen hydrogels; (e-f) Explants 
encapsulated in 2 mg/mL collagen hydrogels; (g-h) Explants encapsulated in 2.5 mg/mL collagen 
hydrogels; (i-j) Explants encapsulated in 2 mg/mL collagen hydrogels crosslinked by 0.25 mM 
genipin; (k-l) Explants encapsulated in 2 mg/mL collagen hydrogels crosslinked by 0.5 mM 
genipin. Scale bar=200 μm. 
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Figure 3.18 Representative confocal microscopic images of DRG explants encapsulated in the 2 
mg/mL collagen gels and cultured for 10 days: (a-b) Explants encapsulated within the gel; (c-d) 
Explants encapsulated in the gel with supplementary PRSCs. 3D reconstruction images (b) (d) of 
confocal microscopy illustrate the morphology of DRG explants within the gels. 
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Figure 3.19 Quantitative analysis of neurite outgrowth of DRG explants encapsulated and cultured 
in collagen and collagen-genipin gels with (+) or without (-) supplementary PRSCs for 10 days: 
(a) Average neurite length per explant (μm, n=3); (b) Neurite density (%, n=3), is defined as the 
number of pixels covered by neurites divided the total number of pixels covered by neurites and 
explant. *p<0.05, **p<0.01, ***p<0.0001 when compared to the DRG explants cultured on 
laminin-coated coverslips. #p<0.05, ##p<0.01, ###p<0.0001 when compared to the DRG explants 
and supplementary PRSCs co-cultured on laminin-coated coverslips. Error bars stand for standard 
error. 
C
o n
tr
o l
C
o l
 1
.5
C
o l
 2
C
o l
 2
.5
C
o l
 2
-G
p  
0 .
2 5
C
o l
 2
-G
p  
0 .
5
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
7 0 0
-
+
* * * * * *
* * *
* * *
** # # #
# # #
# # #
A
v
e
ra
g
e
 n
e
u
ri
te
 l
e
n
g
th
 (

m
)
C
o n
tr
o l
C
o l
 1
.5
C
o l
 2
C
o l
 2
.5
C
o l
 2
-G
p  
0 .
2 5
C
o l
 2
-G
p  
0 .
5
0
1 0
2 0
3 0
4 0
5 0
-
+
# # #
# # #
# # #
N
e
u
ri
te
 d
e
n
s
it
y
 (
%
)
*
( a )
( b )
   56 
3.6.2 Neurite Outgrowth of DRG Neurons Encapsulated in the Hydrogels 
To evaluate the effect of incorporation of PRSCs in the injectable hydrogels on neurite 
outgrowth and axonal regeneration, DRG neurons were encapsulated in the gels and then cultured 
in DMEM/10 % HS medium for 10 days. The morphology of DRG sensory neurons was evaluated 
by immunohistochemistry staining and observed by confocal microscopy. DRG neurons were also 
cultured on laminin-coated coverslips with or without PRSCs and served as the control groups 
(+/-). 
Figure 3.20 shows that all neurons with or without PRSCs (+/-) cultured on laminin-coated 
coverslips are multipolar, and display the longest neurite outgrowth and most branching processes 
when compared to the experimental groups. The co-culture of DRG neurons and PRSCs enhanced 
the number of branching point and the neurite length significantly, which indicated superior neurite 
outgrowth as shown in Figure 3.20 (a-b).  
For neurons cultured in gels without PRSCs (-), incorporation of DRG neurons in physically 
crosslinked collagen gels displayed shorter and less neurite outgrowth when compared to the 
control group (-). Most neurons exhibited unipolar and bipolar morphology. Among all the 
collagen gels, neurons encapsulated by 2 mg/mL collagen gel showed the longest neurite 
regeneration (Figure 3.20 (e)). For collagen-genipin gels, there were no noticeable neurites 
growing within the gels as shown in Figure 3.20 (i) and (k). These results indicate that genipin had 
an inhibitory effect on neurite outgrowth of dissociated sensory neurons. 
For neurons and PRSCs co-cultured in gels, neurons incorporated by collagen gels displayed 
bipolar and multipolar forms. Among all the experimental groups (+), 2 mg/mL collagen gel 
exhibited the longest neurite regeneration (Figure 3.20 (f)). Comparing with no neurite outgrowth 
in collagen-genipin gels (-), very few neurite-bearing neurons were observed in 2 mg/mL collagen 
crosslinked by 0.25 mM genipin (+) (Figure 3.20 (j)).  
Figure 3.21 (b) and (d) display representative 3D reconstruction images of confocal images 
of neurite outgrowth in 2 mg/mL collagen gel without (-) or with (+) PRSCs. It was shown that 
DRG neurites could penetrate and grow within the gels. Incorporation of PRSCs in collagen gels 
resulted in longer neurite elongation and more neurites emerging from the soma. Comparing with 
neurons seeded onto the surface of gels (Figure 3.15), 3D gels provided less favorable environment 
for axonal regeneration and neurite outgrowth of neurons.  
To further explore how the gels enriched with PRSCs affected neurite outgrowth, the results 
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of quantification analysis are shown in Figure 3.22. The average neurite length of neurons for the 
control groups (-/+) was 407 ± 23 and 501 ± 43 μm, and the percentage of neurite-bearing neurons 
was 36 ± 1.4 and 52 ± 1.1 %, respectively. 
For neurons encapsulated in the gels without PRSCs (-), the average neurite length and the 
percentage of neurite-bearing neurons of 2 mg/mL collagen was 200 ± 48 μm and 40 ± 1.5 %, with 
a decrease of 51 % and an increase of 4 % when compared to the control group (-). Neurons 
cultured within the 2 mg/mL collagen gel (-) exhibited better neurite outgrowth than other 
experimental groups. One-way ANOVA determined no significant effect of collagen concentration 
on the neurite length but a significant effect on the percentage of neurite-bearing neurons. No 
neurite-bearing neurons were observed in collagen-genipin gels (-) indicating the inhibitory effect 
of genipin. 
For neurons co-cultured with PRSCs in the gels (+), the average neurite length for 2 mg/mL 
collagen was significantly higher than other experimental groups. Compared to the control group 
(+), the average neurite length and the percentage of neurite-bearing neurons of 2 mg/mL collagen 
gel (+) were 382 ± 34 μm and 37.5 ± 1.6 % with a decrease of 24 and 14 %, respectively. One-way 
ANOVA determined that there was a significant effect of collagen concentration on the average 
neurite length, and the multi-comparison tests showed significant differences between groups, 
except Col 1.5 vs. Col 2.5. Statistically, the percentage of neurite-bearing neurons increased 
significantly with increasing collagen concentration. It was determined that genipin had a 
significant inhibitory effect on neurite outgrowth. Comparing with no neurite-bearing neurons in 
collagen-genipin gels (-), 7 % of the neurons encapsulated in Col 2-Gp 0.25 gel enriched with 
PRSCs exhibited neurite regeneration  
Two-way ANOVA determined PRSCs and collagen concentration had significant effects on 
the average neurite length, while PRSCs had no significant effect on the percentage of neurite-
bearing neurons.  
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Figure 3.20 Confocal microscopy of dissociated DRG neurons encapsulated and cultured within 
collagen and collagen-genipin hydrogels for 10 days. - indicates DRG neurons only and + 
represents DRG neurons and supplementary PRSCs. From top to bottom: (a-b) Neurons cultured 
on laminin-coated coverslips; (c-d) Neurons encapsulated in 1.5 mg/mL collagen hydrogels; (e-f) 
Neurons encapsulated in 2 mg/mL collagen hydrogels; (g-h) Neurons encapsulated in 2.5 mg/mL 
collagen hydrogels; (i-j) Neurons encapsulated in 2 mg/mL collagen hydrogels crosslinked by 0.25 
mM genipin; (k-l) Neurons encapsulated in 2 mg/mL collagen hydrogels crosslinked by 0.5 mM 
genipin. Scale bar=200 μm. 
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Figure 3.21 Representative confocal microscopic images of dissociated DRG neurons 
encapsulated in the 2 mg/mL collagen gel cultured for 10 days: (a-b) Neurons encapsulated in the 
gel; (c-d) Neurons co-cultured with supplementary PRSCs. 3D reconstruction images (b) (d) of 
confocal microscopy illustrate the morphology of DRG neurons cultured within the gel. Scale 
bar=200 μm. 
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Figure 3.22 Quantitative analysis of neurite outgrowth of dissociated DRG neurons encapsulated 
in collagen and collagen-genipin gels with (+) or without (-) supplementary PRSCs cultured for 
10 days: (a) Average neurite length per neuron (μm, n=10); (b) Percentage of neurite bearing 
neurons (%, n=3). *p<0.05, **p<0.01, ***p<0.0001 when compared to the DRG neurons cultured 
on laminin-coated coverslips. #p<0.05, ##p<0.01, ###p<0.0001 when compared to the DRG 
neurons and supplementary PRSCs co-cultured on laminin-coated coverslips. Error bars stand for 
standard error. 
C
o
n
tr
o
l
C
o
l 
1
.5
C
o
l 
2
C
o
l 
2
.5
C
o
l 
2
-G
p
 0
.2
5
C
o
l 
2
-G
p
 0
.5
0
1 0 0
2 0 0
3 0 0
4 0 0
5 0 0
6 0 0
-
+
A
v
e
ra
g
e
 n
e
u
ri
te
 l
e
n
g
th
 (

m
)
# #
# # #
# # #
# # #
# # #
***
***
***
*** ***
C
o
n
tr
o
l
C
o
l 
1
.5
C
o
l 
2
C
o
l 
2
.5
C
o
l 
2
-G
p
 0
.2
5
C
o
l 
2
-G
p
 0
.5
0
1 0
2 0
3 0
4 0
5 0
6 0
-
+
P
e
rc
e
n
ta
g
e
 o
f
 n
e
u
r
it
e
-
b
e
a
ri
n
g
 n
e
u
ro
n
s
 (
%
)
* * * * * *
# # #
# # #
# # #
# # #
*
*
( a )
( b )
   61 
CHAPTER 4  
DISCUSSION 
Injectable hydrogel possesses great potential for nerve injury repair due to the minimally 
invasive procedure, shape-conforming feature, mild gelation conditions and simulation of the 
ECM environment. Biomolecules and supportive cells could be encapsulated within the injectable 
system and released in a controllable manner. In our study, the injectable collagen and collagen-
genipin gels were fabricated and characterized to determine the role of chemical crosslinking in 
the gelation property, porosity, degradability and mechanical property. The neurite outgrowth of 
DRG explant and dissociated neuron as the in vitro cell models were investigated to assess the 
therapeutic potency of injectable hydrogels carrying supplementary PRSCs. It has been widely 
recognized that collagen is a very promising material due to the superior biocompatibility for some 
neural cells [136, 139, 142, 147, 148]. However, the rapid degradation and relatively weak 
structure may impede in vivo application. Genipin, a chemical crosslinker with low cytotoxicity, 
has been used to crosslink the amino groups of collagen to enhance structural stabilization and 
resistance to degradation [130, 133]. In most studies, genipin residues will be washed away prior 
to the cell seeding to reduce potential cytotoxicity [130]. However, as an injectable delivery system, 
the resident crosslinker cannot be displaced before implantation. This research gains new sights 
into the use of injectable collagen and collagen-genipin gels as the cell delivery substrates for nerve 
injury repair. 
4.1 Preparation and Characterization of Collagen-based Gels 
Type I collagen can be used as the injectable hydrogel through either physical or chemical 
crosslinking. Physically crosslinked collagen gels at concentrations of 1.5, 2 and 2.5 mg/mL were 
prepared and gelation occurred at 37 °C within one minute. Collagen under 1.5 mg/mL cannot 
form an intact gel, resulting in the unrealistic handling. With the increase of collagen concentration, 
the gels appeared firmer. Collagen gels (2 mg/mL) chemically crosslinked by addition of 0.25, 0.5, 
1 and 5 mM genepin were prepared. The collagen-genipin gels appeared blue and became darker 
with the increase of time and genipin concentration. The collagen-genipin gels were visually firmer  
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than the collagen-only gels. To quantitatively compare and evaluate the effect of collagen and 
genipin concentration, characterization studies were performed in the aspects of gelation property, 
degradability, swelling behaviour and gel morphology.  
The gelation properties were assessed in the rheological test. It was determined that both the 
physical collagen and chemical collagen-genipin solution can form gels around 31 °C. And the 
gelation time of collagen gels at 37 °C ranged from 27.3 to 35.8 s. The rapid gelation time at body 
temperature makes the use of collagen-based hydrogels for placement in situ highly feasible. The 
gelation time and gelation temperature decreased with increasing collagen concentration, whereas 
there was no significant effect of genipin concentration on these results. It is presumed that the 
gelation of the collagen-genipin mixture may initially result from the thermal crosslinking, and 
later be reinforced by chemical crosslinking. The gel strength of collagen gels at 300 s increased 
from 39.7 Pa at 1.5 mg/mL to 54.3 Pa at 2.5 mg/mL. The addition of genipin (0-5 mM) led to the 
increase of the stiffness from 43.9 to 58.9 Pa, which is presumably induced by the covalent 
crosslinking. The increasing tendency of gel stiffness with increasing collagen and genipin 
concentration has also been reported by other researchers [142, 149].   
Hydrogels can absorb water from the surrounding environment. The swelling behaviour is 
dependent on the crosslinking level and the inner structure of the gel, which is a very important 
parameter correlated with the gel stiffness, porosity and fiber diameter. In our research, the 
swelling ratios of collagen and collagen-genipin gels were evaluated after incubation in PBS for 
24 hours. Swelling ratios decreased with the increase of collagen and genipin concentration. 
Chemically crosslinked collagen-genipin gels displayed reduced swelling behaviour. SEM images 
showed that collagen crosslinked by higher concentration of genipin have a denser fibril network 
and smaller pore size, which might be responsible for the reduced swelling ratios.  
It is reported that the size of the DRG neural cell bodies is 20-30 μm and that their neurite 
diameter ranges from 0.05 to 1.25 μm [150, 151]. An injectable substrate should provide favorable 
mesh size and mechanical properties to support neurite outgrowth. In our research, physical 
collagen gels showed fibrous and porous structures (Figure 3.6) with the average pore size of 3.3 
μm, approximately. The average pore size decreased to 1.5 μm at 0.25 mM genipin with dense 
fibrillar network. With the increase of genipin concentration, the pore structure diminished 
significantly and finally formed very dense fibrillary clusters which might impede neurite 
extension within the gel.  
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To enhance the resistance to degradation, genipin is used as the chemical crosslinker to react 
with the amino groups on collagen [129]. Collagen and collagen-genipin gels were incubated in 
PBS for 1, 7, 15 and 30 days to evaluate the degradability in vitro. After 30 days, the weight 
remaining ratios of physical collagen gels were 55.3, 61.5, and 72.5 %, whereas the weight 
remaining ratio of 2 mg/mL collagen crosslinked by 5 mM genipin increased to 77 %. It was 
determined that the resistance to degradation was significantly improved by the addition of genipin 
effective from Day 15 to Day 30. 
Overall, characterization studies have demonstrated the potency of collagen and collagen 
crosslinked by lower concentration of genipin as the injectable hydrogel. As well, the covalent 
crosslinking induced by genipin can be used to optimize and tune the gel stiffness, porosity, 
swelling behaviour and resistance to degradation.  
4.2 Cytotoxicity Study of Collagen and Collagen-genipin Gels 
Since the residual crosslinkers cannot be effectively washed away prior to the injection and 
gelation in situ, the crosslinkers should ideally be non-cytotoxic. Compared to other crosslinking 
agents for collagen, genipin has been determined about 10,000 times less cytotoxic than 
glutaraldehyde [113]. PRSCs were seeded onto or encapsulated within the injectable hydrogels for 
3 days to evaluate cytotoxicity in 2D and 3D cultures.  
For 2D cell culture, PRSCs exhibited distinct spindle-like phenotype and superior cell 
viability on 1.5, 2 and 2.5 mg/mL collagen gels slightly less than that of the tissue culture plate. 
Cell viability decreased slightly with increasing collagen concentration. The presence of genipin 
led most of the surviving PRSCs to adopt spherical shape, and high concentration of genipin over 
1 mM inhibited cell survival significantly.  
PRSCs were cultured within the 3D hydrogels and evaluated by Live/Dead assay. It was 
determined that the majority of PRSCs encapsulated into 1.5 and 2 mg/mL collagen gels displayed 
typical spindle-shape morphology, whereas PRSCs in 2.5 mg/mL mostly exhibited a round 
phenotype, which indicated a less favorable environment. Cell viability decreased with increasing 
collagen concentration. The majority of PRSCs showed spherical in 2 mg/mL collagen gel 
crosslinked by 0.25 mM genipin with a cell viability of 71 %. Very few PRSCs survived within 2 
mg/mL collagen gels crosslinked by genipin over 0.5 mM, which revealed that higher genipin 
concentration was toxic to PRSCs.  
It is concluded that physically crosslinked collagen gels are very promising as the cellular 
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delivery substrates for nerve injury repair. Collagen gels crosslinked by higher concentration of 
genipin over 1 mM are not permissive for PRSCs survival. As shown in Figure 4.1, PRSCs were 
more sensitive to the genipin concentration in 3D environment potentially resulting from the 
entrapment of genipin residues in the gels. Due to the cytotoxicity of higher concentration of 
genipin confirmed by the 2D and 3D cytotoxic studies, 0.25 and 0.5 mM genipin were used in 
subsequent tests.   
 
Figure 4.1 Comparison of cell viability of PRSCs in 2D and 3D hydrogel system. 
4.3 In Vitro Assessment of DRG Neurite Outgrowth  
DRG tissue is composed of abundant sensory neurons with axons projecting both to the spinal 
cord and distally in the PNS [39]. However, only the peripheral ends can regenerate in vivo [2-4]. 
Since DRG axons can be involved both in the CNS and PNS injury, the neurite outgrowth and 
axonal connections of DRG can be used as a general model to evaluate neural regeneration in vitro. 
In our research, DRG explant and dissociated neuron were exploited as the in vitro cell models to 
study the potency of injectable hydrogels carrying the PRSCs. DRG explants are directly dissected 
from the DRG which include both sensory neurons and glial cells. The unique advantages of the 
DRG explants model are to preserve the original cell interactions in DRG, which are lost in the 
DRG dissociated neurons model. However, comparing with the DRG explants model, dissociated 
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DRG neurons offer a clearer opportunity to unveil how therapies affect axonal regeneration of 
sensory neurons while reducing or controlling other influences. Both in vitro cell models provide 
important insights into combinational therapy of injectable hydrogels containing supplemental 
PRSCs. Based on the results of the cytotoxicity test, collagen (1.5, 2 and 2.5 mg/mL) and genipin 
(0.25 and 0.5 mM) were formulated to prepare the injectable hydrogels.  
4.3.1 Effect of Gel Stiffness on DRG Neurite Outgrowth  
Other researchers have shown that neurite outgrowth from neurons cultured in 3D matrix 
reduces with decreasing the pore size from 1.6 to 0.7 μm [152]. The mechanical strength of a 
matrix plays an important role in neural survival and neurite extension. It has been demonstrated 
that neurons exhibit more branches on softer 2D substrates (50-300 Pa) rather than stiffer substrates 
(300-550 Pa) [153]. Researchers have reported a wide stiffness range for type I collagen gels (e.g. 
2 mg/mL collagen) from 15 to 57 Pa [131, 142, 149, 154]. Our research has determined that the 
gel stiffness of 2 mg/mL collagen was 43.9 Pa and the stiffness was enhanced with increasing the 
collagen and genipin concentration. Figure 4.2 shows the effect of collagen gel stiffness on the 
neurite length of DRG explants and dissociated neurons seeded onto the gels (a) and encapsulated 
within the gels (b). For 2D cultures, explants exhibited the longest neurite elongation on 2.5 mg/mL 
collagen gel (54.3 Pa) and dissociated neurons showed higher neurite length on 2 and 2.5 mg/mL 
collagen gels (43.9 and 54.3Pa). However, there was no significant difference in neurite length 
between DRG explants or dissociated neurons in the 3D culture systems. It has been determined 
that DRG explants and dissociated neurons were less sensitive to the gradient stiffness of 3D 
collagen gels. 
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Figure 4.2 Effect of gel stiffness on the neurite length of DRG explants and dissociated neurons 
seeded on the gels (a) and encapsulated in the gels (b). 
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4.3.2 Neurite Outgrowth of DRG Seeded onto the Hydrogels  
We evaluated the neurite outgrowth of DRG neurons seeded on top of (2D) collagen matrices 
as the preliminary study for subsequent 3D cultures. DRG explants and dissociated neurons were 
seeded onto the hydrogels and cultured for 10 days. NGF was added into the culture medium to 
explore its therapeutic potency for nerve injury repair.  
DRG explants seeded onto the collagen and collagen-genipin gels of all concentrations 
exhibited neurite extension. Explants seeded onto the 2.5 mg/mL collagen gel showed the most 
neurite extension and branches. With the addition of genipin, there were fewer neurites growing 
from the explants comparing with the physical collagen gels. Immunofluorescent images (Figure 
3.13) show that the presence of NGF in the medium results in significant boost of longer and denser 
neurites extension which demonstrates great promise in the use of molecular therapy for promoting 
axon regeneration [97]. Neurite outgrowth in culture was quantitatively evaluated as the average 
neurite length (μm) and neurite density (%). It was determined that the average neurite length and 
neurite density for 2.5 mg/mL collagen gels increased by 61 % and 63 % comparing with the 
control group (laminin-coated coverslip) indicating that these collagen preparations could provide 
a favorable and permissive substrate to support neurite outgrowth. Statistical analysis showed that 
genipin had a greater impact on neurite density rather than on neurite length. Quantitative results 
confirmed that NGF-conditioned medium enhanced both the average neurite length and neurite 
density significantly. In future work, NGF can be controllably delivered by the injectable hydrogels 
for nerve injury repair.  
Comparing with the explant model, detailed branching structures and morphology were 
observed in dissociated DRG neuron culture. DRG neurons cultured on laminin-coated coverslips 
exhibited enormous neurite extension, often with multipolar morphology. When compared to the 
control group, physical collagen gels allowed for neurite growth but with less branching points. 
Also, most of neurons displayed bipolar structure. Neurons seeded onto 1.5 mg/mL collagen gel 
developed shorter neurite structure comparing with other experimental groups, suggesting a 
tendency to form abnormal dendrites, rather than axons. Quantitative results demonstrated that 
neurons seeded onto the collagen gels at higher concentrations possessed longer neurite extension, 
more similar to the explant culture. It was also demonstrated that collagen concentration had no 
significant impact on the percentage of neurite-bearing neurons. Even though neurite outgrowth 
was observed on the collage-genipin gels, the average neurite length and percentage of neurite-
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bearing neurons reduced significantly with increasing genipin concentration. With the addition of 
NGF in the culture medium, longer axons and more neurite-bearing neurons were observed among 
all groups. It was presumed that the addition of NGF played an important role in promoting initial 
neurite formation. Comparing with the explant culture, DRG dissociated neurons were less tolerant 
to the use of genipin in collagen gels and the distinction between dissociated neuron and explant 
culture possibly resulted from more interaction between neurons and glial cells that is preserved 
in explant culture.  
4.3.3 Neurite Outgrowth of DRG Encapsulated in the Hydrogels  
While 2D cultures have demonstrated that neurite outgrowth on physical collagen gels are 
preferable to chemically crosslinked collagen-genipin gels, DRG sensory neurite response to 3D 
collagen-genipin matrices has been rarely reported. A 3D matrix can closely mimic the in vivo 
environment which helps to re-establish normal cell-cell interaction, protect cells from extrinsic 
disturbances, and allow neurites to grow freely in every direction. Cells can be premixed with the 
injectable hydrogel solution and evenly distributed within the gel in situ due to the fast gelation 
property. We encapsulated PRSCs within the hydrogels at a density of 40,000 cells/mL [77-79]. In 
our research, DRG explant and dissociated neuron were used as the in vitro cell models to examine 
the therapeutic potency of injectable hydrogels containing PRSCs for nerve injury repair.  
Immunofluorescence studies showed that both collagen and collagen-genipin gels provided 
favorable and supportive 3D environment for neurite extension of DRG explants but not as well 
as the commonly used laminin-coated surface. Confocal images displayed neurites freely 
penetrating and growing within the 3D gels. Longer neurites extension was observed in physically 
crosslinked collagen gels compared to chemically crosslinked collagen-genipin gels. Neurite 
length and neurite density were measured to quantify the neurite outgrowth. It was determined that 
collagen concentration had no significant effect on neurite outgrowth in these cultures. The 
addition of genipin reduced the numbers of neurites per unit volume significantly. In contrast to 
the 2D study, DRG explants encapsulated into the 2 mg/mL collagen crosslinked by 0.25 mM 
genipin exhibited less neurite sprouting than 2 mg/mL collagen-0.5 mM genipin. While in the 
hydrogels enriched with supplementary PRSCs, the average neurite length and neurite density 
were dramatically enhanced for both collagen and collagen-genipin gels. These neurite outgrowth 
results demonstrated the efficacy of PRSCs for promoting outgrowth from DRG explants and 
confirmed that the idea of injectable hydrogels as the delivery substrates is feasible and promising 
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for nerve injury repair.   
Sensory neurons from adult rats exist in vivo as mostly pseudo-unipolar morphology [39]. A 
pseudo-unipolar neuron has one long neurite with two branches and both branches have 
characteristics in vivo (action potential conduction, myelination, etc.) that identify them as an axon. 
However, neurons cultured on the laminin-coated coverslips as the control group exhibited 
multipolar morphology possibly due to the 2D environment. In this work, specific tests were not 
used to determine whether individual neurites had characteristics of axons or dendrites, but it is 
likely that shorter neurites may have had abnormal dendritic properties, as is sometimes observed 
in cultured adult DRG neurons. 
It was determined that neurites in 3D matrices could penetrate and grow within the gels. 
Comparing with the multipolar morphology in 2D culture, pseudo-unipolar structures were 
observed in physical collagen gels indicating true axonal extension. The pseudo-unipolarization 
might result from the inner structure of the physical collagen gels which closely mimicked the in 
vivo state. Neurons cultured within the 2 mg/mL collagen gel exhibited the best outgrowth 
compared to other experimental groups. However, no neurite-bearing neurons were observed in 
collagen-genipin gels which indicated the inhibitory role of genipin in 3D environment. 
Embedment of PRSCs in collagen gels led to significant enhancement of neurite elongation and 
branching points. Neurons encapsulated in 2 mg/mL collagen gel containing PRSCs exhibited the 
longest neurite outgrowth. Comparing with no neurite outgrowth in collagen-genipin gels without 
PRSCs, very few neurite-bearing neurons were observed in 2 mg/mL collagen crosslinked by 0.25 
mM genipin. Willits et al. have reported that the average neurite length of DRG neurons cultured 
in 2 mg/mL collagen gel for 4 days reached to 136 μm [142]. Our research showed the average 
neurite length for 2 mg/mL collagen gel was 200 μm. With the aid of PRSCs, the average neurite 
length reached to 382 μm. The dissociated DRG neuron model that we used was more sensitive to 
genipin addition to collagen gels than was the explant model, which was correlated to the results 
in 2D tests. The majority of neurites of both the explant and dissociated neuron models extended 
and aligned horizontally indicating the potential guidance of natural polymers. 
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CHAPTER 5  
CONCLUSIONS AND FUTURE WORK 
5.1 Conclusions 
The overall goal of our study is to develop an injectable hydrogel system as the cell-delivery 
matrix and evaluate the therapeutic efficacy of 3D matrix in vitro for nerve injury repair. Physically 
and chemically crosslinked collagen and collagen-genipin hydrogels were prepared and 
characterized in terms of gelation properties, swelling behaviour, degradability and gel 
morphology. The rheometric results indicated that both collagen and collagen-genipin hydrogels 
could gel at pH 7.0, 37 °C within a time period of 40 s, approximately. The rapid gelation time and 
mild gelation condition enable the gel solution localized in situ and evenly encapsulation of 
supportive cells. Immediate gel stiffness of both physical and chemical gels was measured at 300 
s and the results were consistent with the range reported by other researchers, in which neurite 
outgrowth could extend and proliferate. The covalent crosslinking between genipin and collagen 
led to significant enhancement of the gel stiffness. Genipin also has impacts on diminishing the 
swelling behaviour, forming dense microstructure, reducing the pore size, and more importantly, 
improving the resistance to degradation which is the weak spot of the applicability of physical 
collagen gels in vivo.  
Even though genipin has been reported to be low cytotoxicity, most of the biocompatibility 
tests were performed using washed hydrogels, which is not realistic for injectable hydrogels. 
PRSCs were seeded onto or within the gels and cultured for 3 days. It was shown that physical 
collagen gels could easily support the survival of PRSCs, which displayed spindle-like phenotype 
during the culture. Cell viability was inversely proportional to the increase of collagen 
concentration. However, most of the surviving PRSCs cultured onto or within the collagen-genipin 
gels transformed into spherical shape and higher concentration of genipin over 1 mM had a 
significantly inhibitory effect on cell viability. PRSCs were more sensitive to the genipin in 3D 
environment possibly resulting from the entrapment of genipin residues in the gels.  
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DRG explants and dissociated neurons were used as the in vitro cell models to assess the 
potency of injectable hydrogels carrying the PRSCs. A preliminary 2D study was conducted on 
the collagen and collagen-genipin gels and NGF was added into the culture medium to explore the 
efficacy of cellular therapy on the neurite outgrowth. Neurite extensions were observed on the 
collagen and collagen-genipin gels of all concentrations, whereas there were less neurites with the 
presence of genipin when compared to the physical collagen gels. It was also shown DRG 
dissociated neurons were less tolerant to genipin. And this distinction between dissociated neuron 
and explant cultures possibly resulted from the aid of the glial cells preserved in explants culture. 
In contrast to the PRSCs, explants and dissociated neurons seeded onto the collagen gel at higher 
concentration (2.5 mg/mL) exhibited the most neurite extension and branches among all the 
experimental groups. The presence of NGF in the medium resulted in significantly longer and 
denser neurite extension. In future study, NGF could be encapsulated within the injectable 
hydrogels and released in a controllable manner to promote neurite outgrowth. 
Research in DRG neurite response to 3D collagen-genipin matrices has been rarely reported. 
In our research, we encapsulated the DRG in 3D collagen and collagen-genipin hydrogels to mimic 
the in vivo environment and examined the effects of injectable material and supplementary PRSCs 
on neurite outgrowth. It was shown that collagen and collagen-genipin gels allowed the neurites 
of DRG explants to extending within the gels.  
Comparing with the explant culture, DRG dissociated neurons were more sensitive to the 
presence of genipin. Even though neurites of DRG neurons could extend as pseudo-unipolar 
phenotype and presumably axonal extensions were observed within the physical collagen gels, no 
neurite-bearing neurons were observed in collagen-genipin gels. Enriched collagen hydrogels with 
PRSCs could enhance the neurite elongation and branches significantly. And the inhibitory role of 
genipin in neurite outgrowth of dissociated neurons was remedied with the aid of PRSCs. Our 
research lays the groundwork for future in vivo studies using the injectable hydrogels containing 
supportive cells and neurotrophic molecules for nerve injury repair.  
5.2 Future Work 
In order to achieve a better understanding of the chemical crosslinking mechanisms and the 
crosslinking level of collagen-genipin gels, Fourier transform infrared spectroscopy (FTIR) should 
be performed. It has been shown in our studies that genipin can significantly enhance the 
mechanical property and the resistance to degradation. The gel strength test was conducted at 300 
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s due to the equipment availability. However, the gel stiffness may be time dependant. Therefore, 
gel strength in long-term should be investigated. Moreover, as fibrillary network, porosity and 
microstructure are essential factors for axonal regeneration, quantitative analyses of the pore 
diameter and porous distribution should be determined by mercury porosimetry. Furthermore, 
encapsulation of PRSCs within the injectable hydrogel has shown great improvements in 
promoting DRG neurite outgrowth and neutralizing the inhibitory effects of genipin. Loading 
distribution, proliferation and migration studies should be evaluated in the future. Moreover, DRG 
dissociated neurons encapsulated in collagen gels exhibited pseudo-unipolar morphology 
indicating axonal elongation. The cell-material interaction, pseudo-unipolar structures and 
potential re-myelination should be investigated using more specific immunocytochemical 
techniques, and SEM.  
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